{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b3ab12b4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "TAVILY_API_KEY = os.getenv(\"TAVILY_API_KEY\")\n",
    "OPENAI_API_KEY = os.getenv(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "b3d5c77a",
   "metadata": {},
   "outputs": [],
   "source": [
    "### 정보 수집 Agent 실행 결과"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "cc5d209c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "======================================================================\n",
      "🌐 [1단계] 웹 정보 수집\n",
      "======================================================================\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyboardInterrupt\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[3]\u001b[39m\u001b[32m, line 19\u001b[39m\n\u001b[32m     17\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33m🌐 [1단계] 웹 정보 수집\u001b[39m\u001b[33m\"\u001b[39m)\n\u001b[32m     18\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33m=\u001b[39m\u001b[33m\"\u001b[39m*\u001b[32m70\u001b[39m)\n\u001b[32m---> \u001b[39m\u001b[32m19\u001b[39m web_agent = \u001b[43mWebCollectionAgent\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m     20\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtavily_api_key\u001b[49m\u001b[43m=\u001b[49m\u001b[43mos\u001b[49m\u001b[43m.\u001b[49m\u001b[43mgetenv\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mTAVILY_API_KEY\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m     21\u001b[39m \u001b[43m    \u001b[49m\u001b[43mopenai_api_key\u001b[49m\u001b[43m=\u001b[49m\u001b[43mos\u001b[49m\u001b[43m.\u001b[49m\u001b[43mgetenv\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mOPENAI_API_KEY\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[32m     22\u001b[39m \u001b[43m)\u001b[49m\n\u001b[32m     23\u001b[39m state = web_agent.execute(state)\n\u001b[32m     25\u001b[39m \u001b[38;5;66;03m# 2. 전문 자료 수집\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\workspace\\skala_gai\\23-RiskJudgeAgent\\agents\\web_collection.py:37\u001b[39m, in \u001b[36mWebCollectionAgent.__init__\u001b[39m\u001b[34m(self, tavily_api_key, openai_api_key)\u001b[39m\n\u001b[32m     35\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__init__\u001b[39m(\u001b[38;5;28mself\u001b[39m, tavily_api_key: \u001b[38;5;28mstr\u001b[39m, openai_api_key: \u001b[38;5;28mstr\u001b[39m):\n\u001b[32m     36\u001b[39m     \u001b[38;5;28mself\u001b[39m.tavily = TavilyClient(api_key=tavily_api_key)\n\u001b[32m---> \u001b[39m\u001b[32m37\u001b[39m     \u001b[38;5;28mself\u001b[39m.llm = \u001b[43mChatOpenAI\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m     38\u001b[39m \u001b[43m        \u001b[49m\u001b[43mmodel\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgpt-4o-mini\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     39\u001b[39m \u001b[43m        \u001b[49m\u001b[43mapi_key\u001b[49m\u001b[43m=\u001b[49m\u001b[43mopenai_api_key\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m     40\u001b[39m \u001b[43m        \u001b[49m\u001b[43mtemperature\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0\u001b[39;49m\n\u001b[32m     41\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\langchain_core\\load\\serializable.py:130\u001b[39m, in \u001b[36mSerializable.__init__\u001b[39m\u001b[34m(self, *args, **kwargs)\u001b[39m\n\u001b[32m    128\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__init__\u001b[39m(\u001b[38;5;28mself\u001b[39m, *args: Any, **kwargs: Any) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m    129\u001b[39m \u001b[38;5;250m    \u001b[39m\u001b[33;03m\"\"\"\"\"\"\u001b[39;00m  \u001b[38;5;66;03m# noqa: D419\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m130\u001b[39m     \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m.\u001b[49m\u001b[34;43m__init__\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m*\u001b[49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "    \u001b[31m[... skipping hidden 1 frame]\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\langchain_openai\\chat_models\\base.py:591\u001b[39m, in \u001b[36mBaseChatOpenAI.validate_environment\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m    589\u001b[39m         \u001b[38;5;28mself\u001b[39m.http_async_client = httpx.AsyncClient(proxy=\u001b[38;5;28mself\u001b[39m.openai_proxy)\n\u001b[32m    590\u001b[39m     async_specific = {\u001b[33m\"\u001b[39m\u001b[33mhttp_client\u001b[39m\u001b[33m\"\u001b[39m: \u001b[38;5;28mself\u001b[39m.http_async_client}\n\u001b[32m--> \u001b[39m\u001b[32m591\u001b[39m     \u001b[38;5;28mself\u001b[39m.root_async_client = \u001b[43mopenai\u001b[49m\u001b[43m.\u001b[49m\u001b[43mAsyncOpenAI\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    592\u001b[39m \u001b[43m        \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mclient_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    593\u001b[39m \u001b[43m        \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43masync_specific\u001b[49m\u001b[43m,\u001b[49m\u001b[43m  \u001b[49m\u001b[38;5;66;43;03m# type: ignore[arg-type]\u001b[39;49;00m\n\u001b[32m    594\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    595\u001b[39m     \u001b[38;5;28mself\u001b[39m.async_client = \u001b[38;5;28mself\u001b[39m.root_async_client.chat.completions\n\u001b[32m    596\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\openai\\_client.py:509\u001b[39m, in \u001b[36mAsyncOpenAI.__init__\u001b[39m\u001b[34m(self, api_key, organization, project, webhook_secret, base_url, websocket_base_url, timeout, max_retries, default_headers, default_query, http_client, _strict_response_validation)\u001b[39m\n\u001b[32m    506\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m base_url \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m    507\u001b[39m     base_url = \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mhttps://api.openai.com/v1\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m--> \u001b[39m\u001b[32m509\u001b[39m \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m.\u001b[49m\u001b[34;43m__init__\u001b[39;49m\u001b[43m(\u001b[49m\n\u001b[32m    510\u001b[39m \u001b[43m    \u001b[49m\u001b[43mversion\u001b[49m\u001b[43m=\u001b[49m\u001b[43m__version__\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    511\u001b[39m \u001b[43m    \u001b[49m\u001b[43mbase_url\u001b[49m\u001b[43m=\u001b[49m\u001b[43mbase_url\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    512\u001b[39m \u001b[43m    \u001b[49m\u001b[43mmax_retries\u001b[49m\u001b[43m=\u001b[49m\u001b[43mmax_retries\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    513\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    514\u001b[39m \u001b[43m    \u001b[49m\u001b[43mhttp_client\u001b[49m\u001b[43m=\u001b[49m\u001b[43mhttp_client\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    515\u001b[39m \u001b[43m    \u001b[49m\u001b[43mcustom_headers\u001b[49m\u001b[43m=\u001b[49m\u001b[43mdefault_headers\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    516\u001b[39m \u001b[43m    \u001b[49m\u001b[43mcustom_query\u001b[49m\u001b[43m=\u001b[49m\u001b[43mdefault_query\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    517\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_strict_response_validation\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_strict_response_validation\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    518\u001b[39m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    520\u001b[39m \u001b[38;5;28mself\u001b[39m._default_stream_cls = AsyncStream\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\openai\\_base_client.py:1409\u001b[39m, in \u001b[36mAsyncAPIClient.__init__\u001b[39m\u001b[34m(self, version, base_url, _strict_response_validation, max_retries, timeout, http_client, custom_headers, custom_query)\u001b[39m\n\u001b[32m   1395\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m(\n\u001b[32m   1396\u001b[39m         \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mInvalid `http_client` argument; Expected an instance of `httpx.AsyncClient` but got \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mtype\u001b[39m(http_client)\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m\n\u001b[32m   1397\u001b[39m     )\n\u001b[32m   1399\u001b[39m \u001b[38;5;28msuper\u001b[39m().\u001b[34m__init__\u001b[39m(\n\u001b[32m   1400\u001b[39m     version=version,\n\u001b[32m   1401\u001b[39m     base_url=base_url,\n\u001b[32m   (...)\u001b[39m\u001b[32m   1407\u001b[39m     _strict_response_validation=_strict_response_validation,\n\u001b[32m   1408\u001b[39m )\n\u001b[32m-> \u001b[39m\u001b[32m1409\u001b[39m \u001b[38;5;28mself\u001b[39m._client = http_client \u001b[38;5;129;01mor\u001b[39;00m \u001b[43mAsyncHttpxClientWrapper\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m   1410\u001b[39m \u001b[43m    \u001b[49m\u001b[43mbase_url\u001b[49m\u001b[43m=\u001b[49m\u001b[43mbase_url\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1411\u001b[39m \u001b[43m    \u001b[49m\u001b[38;5;66;43;03m# cast to a valid type because mypy doesn't understand our type narrowing\u001b[39;49;00m\n\u001b[32m   1412\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcast\u001b[49m\u001b[43m(\u001b[49m\u001b[43mTimeout\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1413\u001b[39m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\openai\\_base_client.py:1316\u001b[39m, in \u001b[36m_DefaultAsyncHttpxClient.__init__\u001b[39m\u001b[34m(self, **kwargs)\u001b[39m\n\u001b[32m   1314\u001b[39m kwargs.setdefault(\u001b[33m\"\u001b[39m\u001b[33mlimits\u001b[39m\u001b[33m\"\u001b[39m, DEFAULT_CONNECTION_LIMITS)\n\u001b[32m   1315\u001b[39m kwargs.setdefault(\u001b[33m\"\u001b[39m\u001b[33mfollow_redirects\u001b[39m\u001b[33m\"\u001b[39m, \u001b[38;5;28;01mTrue\u001b[39;00m)\n\u001b[32m-> \u001b[39m\u001b[32m1316\u001b[39m \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m.\u001b[49m\u001b[34;43m__init__\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\httpx\\_client.py:1402\u001b[39m, in \u001b[36mAsyncClient.__init__\u001b[39m\u001b[34m(self, auth, params, headers, cookies, verify, cert, http1, http2, proxy, mounts, timeout, follow_redirects, limits, max_redirects, event_hooks, base_url, transport, trust_env, default_encoding)\u001b[39m\n\u001b[32m   1399\u001b[39m allow_env_proxies = trust_env \u001b[38;5;129;01mand\u001b[39;00m transport \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m   1400\u001b[39m proxy_map = \u001b[38;5;28mself\u001b[39m._get_proxy_map(proxy, allow_env_proxies)\n\u001b[32m-> \u001b[39m\u001b[32m1402\u001b[39m \u001b[38;5;28mself\u001b[39m._transport = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_init_transport\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m   1403\u001b[39m \u001b[43m    \u001b[49m\u001b[43mverify\u001b[49m\u001b[43m=\u001b[49m\u001b[43mverify\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1404\u001b[39m \u001b[43m    \u001b[49m\u001b[43mcert\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcert\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1405\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1406\u001b[39m \u001b[43m    \u001b[49m\u001b[43mhttp1\u001b[49m\u001b[43m=\u001b[49m\u001b[43mhttp1\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1407\u001b[39m \u001b[43m    \u001b[49m\u001b[43mhttp2\u001b[49m\u001b[43m=\u001b[49m\u001b[43mhttp2\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1408\u001b[39m \u001b[43m    \u001b[49m\u001b[43mlimits\u001b[49m\u001b[43m=\u001b[49m\u001b[43mlimits\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1409\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtransport\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtransport\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1410\u001b[39m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m   1412\u001b[39m \u001b[38;5;28mself\u001b[39m._mounts: \u001b[38;5;28mdict\u001b[39m[URLPattern, AsyncBaseTransport | \u001b[38;5;28;01mNone\u001b[39;00m] = {\n\u001b[32m   1413\u001b[39m     URLPattern(key): \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m   1414\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m proxy \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m   (...)\u001b[39m\u001b[32m   1424\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m key, proxy \u001b[38;5;129;01min\u001b[39;00m proxy_map.items()\n\u001b[32m   1425\u001b[39m }\n\u001b[32m   1426\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m mounts \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\httpx\\_client.py:1445\u001b[39m, in \u001b[36mAsyncClient._init_transport\u001b[39m\u001b[34m(self, verify, cert, trust_env, http1, http2, limits, transport)\u001b[39m\n\u001b[32m   1442\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m transport \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m   1443\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m transport\n\u001b[32m-> \u001b[39m\u001b[32m1445\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mAsyncHTTPTransport\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m   1446\u001b[39m \u001b[43m    \u001b[49m\u001b[43mverify\u001b[49m\u001b[43m=\u001b[49m\u001b[43mverify\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1447\u001b[39m \u001b[43m    \u001b[49m\u001b[43mcert\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcert\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1448\u001b[39m \u001b[43m    \u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1449\u001b[39m \u001b[43m    \u001b[49m\u001b[43mhttp1\u001b[49m\u001b[43m=\u001b[49m\u001b[43mhttp1\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1450\u001b[39m \u001b[43m    \u001b[49m\u001b[43mhttp2\u001b[49m\u001b[43m=\u001b[49m\u001b[43mhttp2\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1451\u001b[39m \u001b[43m    \u001b[49m\u001b[43mlimits\u001b[49m\u001b[43m=\u001b[49m\u001b[43mlimits\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m   1452\u001b[39m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\httpx\\_transports\\default.py:297\u001b[39m, in \u001b[36mAsyncHTTPTransport.__init__\u001b[39m\u001b[34m(self, verify, cert, trust_env, http1, http2, limits, proxy, uds, local_address, retries, socket_options)\u001b[39m\n\u001b[32m    294\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mhttpcore\u001b[39;00m\n\u001b[32m    296\u001b[39m proxy = Proxy(url=proxy) \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(proxy, (\u001b[38;5;28mstr\u001b[39m, URL)) \u001b[38;5;28;01melse\u001b[39;00m proxy\n\u001b[32m--> \u001b[39m\u001b[32m297\u001b[39m ssl_context = \u001b[43mcreate_ssl_context\u001b[49m\u001b[43m(\u001b[49m\u001b[43mverify\u001b[49m\u001b[43m=\u001b[49m\u001b[43mverify\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcert\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcert\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtrust_env\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    299\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m proxy \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m    300\u001b[39m     \u001b[38;5;28mself\u001b[39m._pool = httpcore.AsyncConnectionPool(\n\u001b[32m    301\u001b[39m         ssl_context=ssl_context,\n\u001b[32m    302\u001b[39m         max_connections=limits.max_connections,\n\u001b[32m   (...)\u001b[39m\u001b[32m    310\u001b[39m         socket_options=socket_options,\n\u001b[32m    311\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\SKAX\\AppData\\Local\\pypoetry\\Cache\\virtualenvs\\langchain-kr-607HAWwd-py3.11\\Lib\\site-packages\\httpx\\_config.py:40\u001b[39m, in \u001b[36mcreate_ssl_context\u001b[39m\u001b[34m(verify, cert, trust_env)\u001b[39m\n\u001b[32m     37\u001b[39m         ctx = ssl.create_default_context(capath=os.environ[\u001b[33m\"\u001b[39m\u001b[33mSSL_CERT_DIR\u001b[39m\u001b[33m\"\u001b[39m])\n\u001b[32m     38\u001b[39m     \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m     39\u001b[39m         \u001b[38;5;66;03m# Default case...\u001b[39;00m\n\u001b[32m---> \u001b[39m\u001b[32m40\u001b[39m         ctx = \u001b[43mssl\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcreate_default_context\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcafile\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcertifi\u001b[49m\u001b[43m.\u001b[49m\u001b[43mwhere\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     41\u001b[39m \u001b[38;5;28;01melif\u001b[39;00m verify \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m:\n\u001b[32m     42\u001b[39m     ctx = ssl.SSLContext(ssl.PROTOCOL_TLS_CLIENT)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\.pyenv\\pyenv-win\\versions\\3.11.9\\Lib\\ssl.py:770\u001b[39m, in \u001b[36mcreate_default_context\u001b[39m\u001b[34m(purpose, cafile, capath, cadata)\u001b[39m\n\u001b[32m    767\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(purpose)\n\u001b[32m    769\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m cafile \u001b[38;5;129;01mor\u001b[39;00m capath \u001b[38;5;129;01mor\u001b[39;00m cadata:\n\u001b[32m--> \u001b[39m\u001b[32m770\u001b[39m     \u001b[43mcontext\u001b[49m\u001b[43m.\u001b[49m\u001b[43mload_verify_locations\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcafile\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcapath\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcadata\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    771\u001b[39m \u001b[38;5;28;01melif\u001b[39;00m context.verify_mode != CERT_NONE:\n\u001b[32m    772\u001b[39m     \u001b[38;5;66;03m# no explicit cafile, capath or cadata but the verify mode is\u001b[39;00m\n\u001b[32m    773\u001b[39m     \u001b[38;5;66;03m# CERT_OPTIONAL or CERT_REQUIRED. Let's try to load default system\u001b[39;00m\n\u001b[32m    774\u001b[39m     \u001b[38;5;66;03m# root CA certificates for the given purpose. This may fail silently.\u001b[39;00m\n\u001b[32m    775\u001b[39m     context.load_default_certs(purpose)\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m: "
     ]
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "from state_schema import create_initial_state\n",
    "from agents import WebCollectionAgent, SpecializedCollectionAgent\n",
    "\n",
    "# 초기화\n",
    "state = create_initial_state(\n",
    "    company_name=\"Vara\",\n",
    "    domain=\"medical\"\n",
    ")\n",
    "\n",
    "# 1. 웹 수집\n",
    "print(\"\\n\" + \"=\"*70)\n",
    "print(\"🌐 [1단계] 웹 정보 수집\")\n",
    "print(\"=\"*70)\n",
    "web_agent = WebCollectionAgent(\n",
    "    tavily_api_key=os.getenv(\"TAVILY_API_KEY\"),\n",
    "    openai_api_key=os.getenv(\"OPENAI_API_KEY\")\n",
    ")\n",
    "state = web_agent.execute(state)\n",
    "\n",
    "# 2. 전문 자료 수집\n",
    "print(\"\\n\" + \"=\"*70)\n",
    "print(\"🎓 [2단계] 전문 자료 수집\")\n",
    "print(\"=\"*70)\n",
    "spec_agent = SpecializedCollectionAgent(\n",
    "    tavily_api_key=os.getenv(\"TAVILY_API_KEY\"),\n",
    "    openai_api_key=os.getenv(\"OPENAI_API_KEY\")\n",
    ")\n",
    "state = spec_agent.execute(state)\n",
    "\n",
    "# 3. 전체 결과 확인\n",
    "print(\"\\n\" + \"=\"*70)\n",
    "print(\"📊 [최종] 수집 결과\")\n",
    "print(\"=\"*70)\n",
    "print(f\"웹 문서: {state['web_collection']['count']}개\")\n",
    "print(f\"전문 문서: {state['specialized_collection']['count']}개\")\n",
    "print(f\"전체: {state['web_collection']['count'] + state['specialized_collection']['count']}개\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51f37fa3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'run_id': 'cae7eadc-429f-431e-a18e-c2d72b021684',\n",
       " 'company_name': 'Vara',\n",
       " 'domain': 'medical',\n",
       " 'start_time': '2025-10-22T20:02:17.891152',\n",
       " 'current_stage': 'init',\n",
       " 'web_collection': {'status': 'partial',\n",
       "  'documents': [{'id': 'web_5ad5cb92',\n",
       "    'url': 'https://www.crunchbase.com/organization/vara',\n",
       "    'title': 'Vara - Crunchbase Company Profile & Funding',\n",
       "    'content': 'Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early.',\n",
       "    'excerpt': 'Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early.',\n",
       "    'two_line_summary': 'Vara is an AI-driven breast cancer screening company from Germany, focused on early detection of\\ndeadly breast cancer. Their technology has been developed, tested, and proven to enhance screening effectiveness.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:33.418165'},\n",
       "   {'id': 'web_9d66a558',\n",
       "    'url': 'https://www.healthtechalpha.com/venture/vara',\n",
       "    'title': 'Vara Company Profile: Funding, Investors & Partnerships',\n",
       "    'content': 'Vara is the developer of breast cancer screening software powered by artificial intelligence. Vara has formed alliances with radiology groups and',\n",
       "    'excerpt': 'Vara is the developer of breast cancer screening software powered by artificial intelligence. Vara has formed alliances with radiology groups and',\n",
       "    'two_line_summary': 'Vara develops AI-powered breast cancer screening software and collaborates with radiology groups to enhance\\ndiagnostic capabilities. Their technology aims to improve early detection and treatment outcomes for patients.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:36.032966'},\n",
       "   {'id': 'web_760f58e9',\n",
       "    'url': 'https://nextdigitalhealth.com/ventures/vara/',\n",
       "    'title': 'Vara - Berlin',\n",
       "    'content': \"Vara is a health technology company based in Berlin, Germany. Founded in 2018, it focuses on increasing patients' access to data-driven breast cancer\",\n",
       "    'excerpt': \"Vara is a health technology company based in Berlin, Germany. Founded in 2018, it focuses on increasing patients' access to data-driven breast cancer\",\n",
       "    'two_line_summary': 'Vara, a Berlin-based health tech company founded in 2018, aims\\nto enhance patient access to data-driven solutions for breast cancer.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:37.839148'},\n",
       "   {'id': 'web_9d57be43',\n",
       "    'url': 'https://app.dealroom.co/companies/vara',\n",
       "    'title': 'Vara company information, funding & investors',\n",
       "    'content': \"Vara company information, funding & investors | Dealroom.co Image 1: Vara *   ai for medical imaging | Oct 2024* | * VI Partners * IBB Ventures * EQT Ventures * Plug and Play * Think.Health * Soleria Capital * Evo Partners * Make Visions capital * Schmidbauer Management Holding | $8.9m | Early VC | Image 5: Merantix Image 6: Think.Health Image 8: Med360 Image 9: Soleria Capital Image 13: EQT Ventures Image 15: Make Visions capital Image 19: Merantix Capital Vara is a healthcare technology startup that aims to revolutionize breast cancer screening through the use of artificial intelligence (AI). The company's platform is backed by clinical evidence, which shows how Vara is redefining breast cancer screening for the better.\",\n",
       "    'excerpt': 'Vara company information, funding & investors | Dealroom.co Image 1: Vara *   ai for medical imaging | Oct 2024* | * VI Partners * IBB Ventures * EQT Ventures * Plug and Play * Think.Health * Soleria ',\n",
       "    'two_line_summary': 'Vara is a healthcare technology startup focused on enhancing breast cancer screening using AI,\\nsupported by clinical evidence. The company has raised $8.9 million in early venture capital funding.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:40.870195'},\n",
       "   {'id': 'web_61d56f8a',\n",
       "    'url': 'https://www.cbinsights.com/company/vara-healthcare',\n",
       "    'title': 'Vara - Products, Competitors, Financials, Employees ...',\n",
       "    'content': '# Vara vara.ai ## About Vara Vara is included in **4 Expert Collections,** including **Artificial Intelligence (AI)**. Vara BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received a new CE certificate for its new breast-imaging AI – the only on the market allowed to operate as an independent second reader for both screening and diagnostic use. Now, by pairing population-wide, real-world results with automatic real-time monitoring, we’re offering a credible, scalable path for AI as an independent reader – and we’re grateful the regulator acknowledged this approach.” About Vara: Vara builds AI and cloud workflow tools for breast imaging, helping radiologists detect cancer earlier while reducing unnecessary recalls and reading time. * How much did Vara raise?',\n",
       "    'excerpt': '# Vara vara.ai ## About Vara Vara is included in **4 Expert Collections,** including **Artificial Intelligence (AI)**. Vara BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara announced today it received a',\n",
       "    'two_line_summary': 'Vara has received a CE certificate for its breast-imaging AI, enabling it to function as an independent\\nsecond reader for screening and diagnostic use. The technology aims to enhance cancer detection and streamline radiology workflows.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-10-15',\n",
       "    'age_days': 7,\n",
       "    'is_recent': True,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.6,\n",
       "    'reliability_reasons': ['recent within policy window'],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:43.805926'},\n",
       "   {'id': 'web_86f287fe',\n",
       "    'url': 'https://spasciences.com/products/vara?srsltid=AfmBOopUEsaA2CVx5YMX5kuS39TdbU-p-7UKz2SKjzARvqrMl88TsgNF',\n",
       "    'title': 'VARA - Spa Sciences',\n",
       "    'content': 'FEATURES & TECHNOLOGY. 5 INTERCHANGEABLE TREATMENT HEADS. VARA comes with 5 interchangeable treatment heads for a customized experience and targeted muscle',\n",
       "    'excerpt': 'FEATURES & TECHNOLOGY. 5 INTERCHANGEABLE TREATMENT HEADS. VARA comes with 5 interchangeable treatment heads for a customized experience and targeted muscle',\n",
       "    'two_line_summary': 'The VARA device features five interchangeable treatment heads, allowing for a personalized and\\ntargeted muscle treatment experience. This customization enhances its effectiveness for various therapeutic needs.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:46.057171'},\n",
       "   {'id': 'web_ff0a4afd',\n",
       "    'url': 'https://www.vara.ai/technology',\n",
       "    'title': 'Vara | Technology',\n",
       "    'content': \"*   Description LinkedIn sets this cookie to store performed actions on the website. [](https://www.vara.ai/) [Products](https://www.vara.ai/technology)[Research](https://www.vara.ai/technology)[About Us](https://www.vara.ai/technology)[Screening](https://www.vara.ai/technology)[Impact & Implementation](https://www.vara.ai/technology)[Careers](https://www.vara.ai/technology)[Contact Us](https://www.vara.ai/technology) [About Us](https://www.vara.ai/about-us) [Leadership Team](https://www.vara.ai/leadership) [Technology](https://www.vara.ai/technology) [Blog](https://www.vara.ai/blog) ![Image 5](blob:http://localhost/55169eef3ee42f25b023af78c5756409)![Image 6](https://www.vara.ai/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftechnology-hero.b8b0f4b3.jpg&w=3840&q=75) ![Image 7](https://www.vara.ai/images/team/renate.jpg) ![Image 8](https://www.vara.ai/images/team/kirsten.jpg) ![Image 9](https://www.vara.ai/images/team/timo.jpg) ![Image 10](https://www.vara.ai/images/team/thomas.jpg) ![Image 11](https://www.vara.ai/images/team/thilo.jpg) ![Image 12](https://www.vara.ai/images/team/volker.jpg) ![Image 13](blob:http://localhost/0dadfabb32e0286e77c5ec95327777fd)![Image 14](https://www.vara.ai/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftechnology-2.8389ab5b.png&w=2048&q=75) That’s why Vara provides screening performance metrics in real-time — and why we’re constantly observing the interactions between radiologists and our AI. ![Image 15](blob:http://localhost/16fbfe22deeaff82c529a0aa9f23bf03)![Image 16](https://www.vara.ai/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftechnology-3.a7d7cd28.png&w=2048&q=75) Vara integrates AI technology and automation directly into a highly-optimized breast-screening-compliant viewer. ![Image 17](blob:http://localhost/ead4064d2f81bd30450478bbcb20818a)![Image 18](https://www.vara.ai/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftechnology-4.799b1a2b.png&w=1920&q=75) ![Image 19](blob:http://localhost/be62142e9e67489f5a32664eb515fb36)![Image 20](https://www.vara.ai/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftechnology-5.df7b9915.png&w=1920&q=75) [](https://www.vara.ai/) [About Us](https://www.vara.ai/technology) [Products](https://www.vara.ai/technology) [Screening](https://www.vara.ai/technology) [Impact & Implementation](https://www.vara.ai/technology) [News & Media](https://www.vara.ai/technology) [Decision Referral](https://www.vara.ai/technology) [Publications](https://www.vara.ai/technology) [PRAIM Study](https://www.vara.ai/technology) [Monitoring](https://www.vara.ai/technology) [Let's connect](https://www.vara.ai/technology) [Careers](https://www.vara.ai/technology) [[Vara India](https://www.vara.ai/technology)](https://in.vara.ai/) [Legal Disclosure](https://www.vara.ai/legal-disclosure) [Disclaimer](https://www.vara.ai/disclaimer) [Privacy Policy](https://www.vara.ai/privacy-policy)\",\n",
       "    'excerpt': '*   Description LinkedIn sets this cookie to store performed actions on the website. [](https://www.vara.ai/) [Products](https://www.vara.ai/technology)[Research](https://www.vara.ai/technology)[About',\n",
       "    'two_line_summary': 'Vara integrates AI technology into breast screening, providing real-time performance metrics and optimizing interactions\\nbetween radiologists and AI. Their platform enhances compliance and efficiency in the screening process.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:48.352995'},\n",
       "   {'id': 'web_ce46bb19',\n",
       "    'url': 'https://wiki.vara.network/docs/about',\n",
       "    'title': 'Vara Capabilities | Vara Network Documentation Portal',\n",
       "    'content': 'Web3 fuels the development of innovative decentralized applications (dApps) and assets like Decentralized finance (DeFi), Decentralized exchanges (DEX), Decentralized marketplaces and Gaming platforms, Non-fungible tokens (NFTs), Social tokens and more. Utilizing the Substrate-based Gear Protocol technology, Vara serves as a developer-friendly programming platform for decentralized applications deployed on the Layer-1 standalone network. Vara offers developers an ecosystem for creating decentralized applications at an advanced level within the Web3 industry. The Gear Protocol provides a developer-friendly framework for creating fully on-chain games and deploying them on a decentralized network, such as Vara. Features like continuous automation (via delayed messages), payless and signless transactions, gas reservation, and more serve as essential tools for developers striving to craft successful games within the Vara decentralized network.',\n",
       "    'excerpt': 'Web3 fuels the development of innovative decentralized applications (dApps) and assets like Decentralized finance (DeFi), Decentralized exchanges (DEX), Decentralized marketplaces and Gaming platforms',\n",
       "    'two_line_summary': 'Vara is a developer-friendly platform for creating decentralized applications using the Gear Protocol on\\na Layer-1 network, offering tools for advanced dApp development, including gaming and automation features.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:50.703584'},\n",
       "   {'id': 'web_20929202',\n",
       "    'url': 'https://www.varatechnology.com/infrastructure',\n",
       "    'title': 'Infrastructure - Vara Technology',\n",
       "    'content': 'Vara innovates logistics and highways with RFID and IoT solutions, enhancing efficiency and safety while reducing costs. Our technologies include electronic',\n",
       "    'excerpt': 'Vara innovates logistics and highways with RFID and IoT solutions, enhancing efficiency and safety while reducing costs. Our technologies include electronic',\n",
       "    'two_line_summary': 'Vara Technology enhances logistics and highways through RFID and IoT solutions, improving efficiency\\nand safety while lowering costs. Their innovations focus on electronic systems for streamlined operations.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:52.615520'},\n",
       "   {'id': 'web_2768f26e',\n",
       "    'url': 'https://www.varatechnology.com/rfid',\n",
       "    'title': 'RFID - Toll Management System - Vara Technology',\n",
       "    'content': \"Vara's tolling system employs a blend of advanced technologies and methods, enabling you to centrally manage toll operations with a single, integrated solution.\",\n",
       "    'excerpt': \"Vara's tolling system employs a blend of advanced technologies and methods, enabling you to centrally manage toll operations with a single, integrated solution.\",\n",
       "    'two_line_summary': \"Vara's tolling system integrates advanced technologies for centralized management of toll operations,\\nproviding a comprehensive solution. This approach enhances efficiency and streamlines processes for users.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:54.388832'},\n",
       "   {'id': 'web_9b57091a',\n",
       "    'url': 'https://www.eqs-news.com/news/media/vara-q3-2025-consensus-estimates-for-shell-plc/14ad1c3f-998a-4c3b-a844-f152fc5c5183_en',\n",
       "    'title': 'VARA Q3 2025 Consensus Estimates for Shell plc | Media - EQS News',\n",
       "    'content': 'Vara Research GmbH. VARA Q3 2025 ... 22.10.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News – a service of EQS Group.',\n",
       "    'excerpt': 'Vara Research GmbH. VARA Q3 2025 ... 22.10.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News – a service of EQS Group.',\n",
       "    'two_line_summary': 'Vara Research GmbH released Q3 2025 consensus estimates for Shell PLC on October\\n22, 2025. The information was disseminated via EQS News, a service of EQS Group.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-10-22',\n",
       "    'age_days': 0,\n",
       "    'is_recent': True,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.6,\n",
       "    'reliability_reasons': ['recent within policy window'],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:02:56.912685'},\n",
       "   {'id': 'web_59ba529a',\n",
       "    'url': 'https://www.vara.ae/en/news/',\n",
       "    'title': 'Vara News - Virtual Assets Regulatory Authority (VARA)',\n",
       "    'content': 'The Dubai Virtual Assets Regulatory Authority (VARA) issues this circular to all regulated VASPs regarding the publication of the updated UAE National Risk Assessment (NRA) on Anti-Money Laundering (AML), Combating the Financing of Terrorism (CFT), and Proliferation Financing (PF). Komainu, a regulated digital asset custody provider built by institutions for institutions, has announced today that it has received the minimal viable product (MVP) licence from Dubai’s Virtual Assets Regulatory Authority (VARA), following the issuance of its provisional approval in July 2022. Binance, the leading global blockchain services provider, has announced today that it has received the Minimal Viable Product (MVP) license from Dubai’s Virtual Asset Regulatory Authority (VARA), following the issuance of its provisional license in March 2022.',\n",
       "    'excerpt': 'The Dubai Virtual Assets Regulatory Authority (VARA) issues this circular to all regulated VASPs regarding the publication of the updated UAE National Risk Assessment (NRA) on Anti-Money Laundering (A',\n",
       "    'two_line_summary': 'The Dubai Virtual Assets Regulatory Authority (VARA) has updated the UAE National Risk Assessment on AML,\\nCFT, and PF. Komainu and Binance have both received MVP licenses from VARA, enhancing their regulatory compliance.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:01.770968'},\n",
       "   {'id': 'web_46a29af3',\n",
       "    'url': 'https://vara.network/news',\n",
       "    'title': 'Vara News - Vara Network',\n",
       "    'content': 'Stay up to date with the latest releases and updates from the development team by subscribing to@GearVaraDev Telegram channel Main page # Vara News * Updates ### From Code to Cosmos: Creating a Blockchain Game with AI on Vara * Updates ### Building a Vara-Based Token App: A Simple Guide for Developers Using React and VFT * Updates ### Vara Monthly Recap | August 2025 * Updates ### Fractured But Whole: Can Ethereum’s Fragmentation Challenge Be Solved? * Updates ### Vara Monthly Recap | July 2025 * Updates ### From Ping to Pong: Cross-Chain App Dev with Vara & Ethereum ## Media about us News | Vara Network',\n",
       "    'excerpt': 'Stay up to date with the latest releases and updates from the development team by subscribing to@GearVaraDev Telegram channel Main page # Vara News * Updates ### From Code to Cosmos: Creating a Blockc',\n",
       "    'two_line_summary': \"Stay informed on Vara's latest developments by subscribing to their Telegram channel.\\nRecent updates include blockchain game creation, token app guides, and monthly recaps.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:04.747606'},\n",
       "   {'id': 'web_403bb829',\n",
       "    'url': 'https://www.prnewswire.com/news-releases/mantra-secures-first-vara-defi-license-paving-the-way-for-global-growth-and-innovation-in-financial-products-302380163.html',\n",
       "    'title': 'MANTRA Secures First VARA DeFi License, Paving the Way for ...',\n",
       "    'content': \"DUBAI, UAE, Feb. 19, 2025 /PRNewswire/ --\\xa0**MANTRA Finance FZE (MANTRA), a leading decentralized finance (DeFi) platform operated by MANTRA Group, today announces it has successfully obtained a Virtual Asset Service Provider (VASP) license from Dubai's Virtual Assets Regulatory Authority (VARA), to operate as a Virtual Asset Exchange, as well as provide Broker-Dealer and Management and Investment Services.** The VARA license will support not just MANTRA's global footprint as it introduces a range of innovative, regulatory-compliant financial products tailored to the evolving needs of investors around the world, but position it to further scale operations in the Middle East focused on the tokenization of real world assets (RWAs). MANTRA, a layer 1 blockchain purpose-built for tokenized real world assets (RWAs), today announces the first tranche of its buyback of OM tokens,...\",\n",
       "    'excerpt': 'DUBAI, UAE, Feb. 19, 2025 /PRNewswire/ --\\xa0**MANTRA Finance FZE (MANTRA), a leading decentralized finance (DeFi) platform operated by MANTRA Group, today announces it has successfully obtained a Virtua',\n",
       "    'two_line_summary': \"MANTRA Finance has secured a VASP license from Dubai's VARA, enabling it to operate as a Virtual Asset\\nExchange and expand its innovative financial products globally. This positions MANTRA to enhance its operations in the Middle East.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-02-19',\n",
       "    'age_days': 245,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:07.578529'},\n",
       "   {'id': 'web_89ca32fb',\n",
       "    'url': 'https://www.businesswire.com/news/home/20250929442675/en/Tokinvest-Secures-VARAs-First-Multi-Asset-Issuance-Licence-Launches-RWA-platform-Fully-Sells-Out-First-Tokenised-Racehorse-and-Closes-%243.2M-Pre-Seed-Funding',\n",
       "    'title': \"Tokinvest Secures VARA's First Multi-Asset Issuance Licence ...\",\n",
       "    'content': 'DUBAI, United Arab Emirates--(BUSINESS WIRE)--**Tokinvest****,** the regulated marketplace for real-world asset (RWA) tokenisation, today announces three major milestones: receipt of the **first** full multi-asset issuance licence from Dubai’s Virtual Assets Regulatory Authority (VARA), the complete sale of its first tokenised racehorse, and the close of a $3.2 million pre-seed funding round. DUBAI, United Arab Emirates--(BUSINESS WIRE)--Tokinvest DMCC, a pioneering marketplace for real-world asset tokenisation and provisional Virtual Assets Regulatory Authority (VARA) licensed brokerage, is excited to announce the expansion of its collaboration with Universal Digital Payments Network (UDPN) and the launch of a Tokenised Deposit and Stablecoin Management System. DUBAI, United Arab Emirates--(BUSINESS WIRE)--Tokinvest, a pioneering marketplace for real-world asset tokenisation, today announces it has raised $500,000 in pre-seed funding from several strategic investors.',\n",
       "    'excerpt': 'DUBAI, United Arab Emirates--(BUSINESS WIRE)--**Tokinvest****,** the regulated marketplace for real-world asset (RWA) tokenisation, today announces three major milestones: receipt of the **first** ful',\n",
       "    'two_line_summary': \"Tokinvest has secured VARA's first multi-asset issuance license, fully sold its first tokenized racehorse, and closed\\na $3.2 million pre-seed funding round. The company is expanding its collaboration with Universal Digital Payments Network.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-09-29',\n",
       "    'age_days': 23,\n",
       "    'is_recent': True,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.6,\n",
       "    'reliability_reasons': ['recent within policy window'],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:10.166953'},\n",
       "   {'id': 'web_b80cc514',\n",
       "    'url': 'https://itsartlaw.org/art-law/pre-post-vara-a-study-of-the-protection-of-public-art/',\n",
       "    'title': 'Pre & Post VARA: A Study of the Protection of Public Art',\n",
       "    'content': 'The following article analyzes the landmark pre-VARA case, Richard Serra v. US General Services Admin, against two recent cases that cite',\n",
       "    'excerpt': 'The following article analyzes the landmark pre-VARA case, Richard Serra v. US General Services Admin, against two recent cases that cite',\n",
       "    'two_line_summary': 'The article examines the pre-VARA case of Richard Serra v. US General Services\\nAdmin and compares it to two recent cases referencing the Visual Artists Rights Act.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:14.325906'},\n",
       "   {'id': 'web_805bcdaf',\n",
       "    'url': 'https://www.afslaw.com/perspectives/alerts/painting-over-controversy-navigating-vara-and-controversial-canvases',\n",
       "    'title': 'Painting Over Controversy: Navigating VARA and ... - ArentFox Schiff',\n",
       "    'content': 'The US Court of Appeals for the Second Circuit ruled that Vermont Law School’s decision to cover a pair of murals, which the school and many of its students found to be offensive, did not violate the artist Samuel Kerson’s rights under the 1990 Visual Artists Rights Act (VARA). The district court denied Kerson’s claims based on its finding that concealment of site-specific artwork does not violate an artist’s moral rights under VARA. While VARA aims to protect the integrity of an artist’s work, this case serves as an example of how the statute and courts seek to strike a balance in the case of site-specific works between artists’ rights to protect their reputations and artworks, and property owners’ rights to control the works in their possession.',\n",
       "    'excerpt': 'The US Court of Appeals for the Second Circuit ruled that Vermont Law School’s decision to cover a pair of murals, which the school and many of its students found to be offensive, did not violate the ',\n",
       "    'two_line_summary': \"The Second Circuit upheld Vermont Law School's decision to cover murals, ruling it didn't violate artist Samuel\\nKerson's rights under VARA. This case highlights the balance between artists' moral rights and property owners' control.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:18.996004'},\n",
       "   {'id': 'web_ab80fbf2',\n",
       "    'url': 'https://www.herrick.com/content/uploads/2016/05/Street-Art-and-VARA-The-Intersection-of-Copyright-and-Real-Estate.pdf',\n",
       "    'title': '[PDF] Street Art and VARA: The Intersection of Copyright and Real Estate',\n",
       "    'content': 'One New York case rejected “recognized stature” where the work, while meritorious, was created “solely as a display piece for a one-time event.”21 Another case refused pro\\xad tection because the work had been commissioned for placement in the defendants’ private yard, which was obscured by hedges from public view, thus precluding recognition.22 The 5Pointz court left open the question of “recognized stature” for trial, and cautioned that “defendants are exposed to potentially significant monetary damages if it is ultimately determined after trial that the plaintiffs’ works were of ‘recognized stature.’”23 In denying preliminary injunctive relief, which requires a showing of irreparable harm, the 5Pointz court cited “the transient nature of the plaintiffs’ works” based on evidence that while the lead art\\xad ist-plaintiff believed the “24 works in issue were to be permanent\\xad ly displayed on the buildings, he always knew that the buildings were coming down—and that his paintings, as well as the others which he allowed to be placed on the walls, would be destroyed.” Nevertheless, with respect to the potential for money damages, the court held that “VARA protects even temporary works from de\\xad struction…,” thus implicitly acknowledging they were sufficiently “fixed” for copyright purposes.24 This sets up an inherent contra\\xad diction: If the works qualified for any VARA protection—includ\\xad ing money damages—they must be copyrightable and thus meet the “fixation” test.',\n",
       "    'excerpt': 'One New York case rejected “recognized stature” where the work, while meritorious, was created “solely as a display piece for a one-time event.”21 Another case refused pro\\xad tection because the work ha',\n",
       "    'two_line_summary': 'The 5Pointz court highlighted the complexities of \"recognized stature\" under VARA, noting that even temporary works\\ncan receive copyright protection despite their transient nature. This raises contradictions regarding their fixation status for damages.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:21.160561'},\n",
       "   {'id': 'web_76c98499',\n",
       "    'url': 'https://harvardlawreview.org/wp-content/uploads/2021/03/134-Harv.-L.-Rev.-1881.pdf',\n",
       "    'title': '[PDF] RECENT CASES - Harvard Law Review',\n",
       "    'content': 'perpetual moral rights under VARA allow her to prevent the collector from modifying or altering the work even after she transfers title.52 That being the case,',\n",
       "    'excerpt': 'perpetual moral rights under VARA allow her to prevent the collector from modifying or altering the work even after she transfers title.52 That being the case,',\n",
       "    'two_line_summary': 'Under VARA, artists retain perpetual moral rights, enabling them to prevent modifications or alterations to their\\nwork even after transferring ownership. This protection underscores the importance of preserving the integrity of artistic creations.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:23.353622'},\n",
       "   {'id': 'web_cf03ac9e',\n",
       "    'url': 'https://www.grossmanllp.com/two-recent-cases-highlight-the-scope-of-artists-protections-under-vara',\n",
       "    'title': 'Two Recent Cases Highlight The Scope Of Artists Protections Under ...',\n",
       "    'content': 'Two lawsuits have highlighted some of the ongoing questions about how VARA protects the rights of artists, particularly when the art at issue has been created',\n",
       "    'excerpt': 'Two lawsuits have highlighted some of the ongoing questions about how VARA protects the rights of artists, particularly when the art at issue has been created',\n",
       "    'two_line_summary': \"Recent lawsuits underscore the complexities of the Visual Artists Rights Act (VARA) in\\nsafeguarding artists' rights, especially concerning the ownership and treatment of their created works.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:25.420573'},\n",
       "   {'id': 'web_e8dd74ab',\n",
       "    'url': 'https://www.linkedin.com/pulse/dubais-vara-white-paper-framework-global-benchmark-charlotte-hill-apqte',\n",
       "    'title': \"Dubai's VARA White Paper Framework: A Global Benchmark for ...\",\n",
       "    'content': 'On 19 May, 2025, the Dubai Virtual Assets Regulatory Authority (VARA) issued a landmark white paper establishing detailed requirement frameworks',\n",
       "    'excerpt': 'On 19 May, 2025, the Dubai Virtual Assets Regulatory Authority (VARA) issued a landmark white paper establishing detailed requirement frameworks',\n",
       "    'two_line_summary': \"On May 19, 2025, Dubai's Virtual Assets Regulatory Authority (VARA) released a significant white paper outlining\\ncomprehensive regulatory frameworks for virtual assets. This initiative aims to set global benchmarks in the industry.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-05-19',\n",
       "    'age_days': 156,\n",
       "    'is_recent': True,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.6,\n",
       "    'reliability_reasons': ['recent within policy window'],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:27.623764'},\n",
       "   {'id': 'web_dd300c38',\n",
       "    'url': 'https://blog.beyondi.co/7-critical-vara-whitepaper-requirements-for-asset-tokenization-in-the-mena-region-vs-a50e032a2b3c',\n",
       "    'title': 'PART 1: 7 Critical VARA Whitepaper Requirements for Asset ...',\n",
       "    'content': '# PART 1: 7 Critical VARA Whitepaper Requirements for Asset Tokenization in the MENA Region vs. This article unpacks **seven critical whitepaper requirements** under the **Virtual Assets Regulatory Authority (VARA)** framework for asset-referenced tokens in the MENA region and contrasts them with obligations under the **EU’s Markets in Crypto-Assets Regulation (MiCA)** and **Swiss FINMA ICO Guidelines**. Although VARA, MiCA and FINMA do not mandate specific on-chain interfaces, aligning your issuance with any of these standards will facilitate broad market integration and future-proof your token’s utility and compliance. Navigating the detailed whitepaper requirements of VARA, MiCA and FINMA is critical for successful asset tokenization.',\n",
       "    'excerpt': '# PART 1: 7 Critical VARA Whitepaper Requirements for Asset Tokenization in the MENA Region vs. This article unpacks **seven critical whitepaper requirements** under the **Virtual Assets Regulatory Au',\n",
       "    'two_line_summary': \"The article outlines seven essential VARA whitepaper requirements for asset tokenization in the MENA region, comparing them with EU's\\nMiCA and Swiss FINMA guidelines to ensure compliance and market integration. Understanding these regulations is vital for successful token issuance.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:31.753876'},\n",
       "   {'id': 'web_f5dba820',\n",
       "    'url': 'https://www.varatechnology.com/whitepapers',\n",
       "    'title': 'Whitepapers - Vara Technology',\n",
       "    'content': \"Explore VARA Technology's industry-leading whitepapers on advanced services and solutions. Stay informed with expert insights and innovation trends.\",\n",
       "    'excerpt': \"Explore VARA Technology's industry-leading whitepapers on advanced services and solutions. Stay informed with expert insights and innovation trends.\",\n",
       "    'two_line_summary': 'VARA Technology offers a collection of whitepapers featuring expert insights on advanced\\nservices and innovation trends. Stay updated on industry-leading solutions through their comprehensive resources.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:34.289991'},\n",
       "   {'id': 'web_ee4737f5',\n",
       "    'url': 'https://rulebooks.vara.ae/rulebook/schedule-1-va-whitepaper-requirements',\n",
       "    'title': 'Schedule 1 – VA Whitepaper Requirements - the VARA Rulebook',\n",
       "    'content': \"The Virtual Assets Regulatory Authority (VARA) is the sole authority regulating virtual assets across Dubai's free zones and mainland, except within the\",\n",
       "    'excerpt': \"The Virtual Assets Regulatory Authority (VARA) is the sole authority regulating virtual assets across Dubai's free zones and mainland, except within the\",\n",
       "    'two_line_summary': \"The Virtual Assets Regulatory Authority (VARA) oversees the regulation of virtual assets in Dubai's free\\nzones and mainland. It establishes guidelines to ensure compliance and safety in the virtual asset sector.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:36.968215'},\n",
       "   {'id': 'web_40283cf8',\n",
       "    'url': 'https://uat3.varatechnology.com/downloadpdf/whitepaper/',\n",
       "    'title': 'Whitepaper - Vara Technology',\n",
       "    'content': 'Whitepaper · Previous PostIdentity Management, Aadhar and Replicated State Machines · Next PostBrochure. Share Tweet Share. About Us. Company Overview',\n",
       "    'excerpt': 'Whitepaper · Previous PostIdentity Management, Aadhar and Replicated State Machines · Next PostBrochure. Share Tweet Share. About Us. Company Overview',\n",
       "    'two_line_summary': 'The URL leads to a whitepaper on identity management and technology solutions. It\\nalso includes links to previous and next posts, along with a company overview.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:39.253127'},\n",
       "   {'id': 'web_714c6a90',\n",
       "    'url': 'https://www.thenormalschool.com/blog/2025/4/16/vauhini-vara',\n",
       "    'title': 'A Normal Interview with Vauhini Vara by Talia Kolluri',\n",
       "    'content': 'In this email interview, Vara and I talked about her relationship to technology, her fascinating creative process, and where vulnerability in art can take us.',\n",
       "    'excerpt': 'In this email interview, Vara and I talked about her relationship to technology, her fascinating creative process, and where vulnerability in art can take us.',\n",
       "    'two_line_summary': 'Vauhini Vara discusses her connection to technology and her creative process in an email interview,\\nexploring the role of vulnerability in art. The conversation highlights the transformative potential of artistic expression.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-04-16',\n",
       "    'age_days': 189,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:42.135189'},\n",
       "   {'id': 'web_0559581a',\n",
       "    'url': 'https://massreview.org/node/11541/',\n",
       "    'title': 'Living Documents: An Interview with Vauhini Vara | Mass Review',\n",
       "    'content': 'Vauhini Vara views her writing as \"living documents,\" exploring themes of disintegration, decay, and loss, and the influence of capitalism.',\n",
       "    'excerpt': 'Vauhini Vara views her writing as \"living documents,\" exploring themes of disintegration, decay, and loss, and the influence of capitalism.',\n",
       "    'two_line_summary': 'Vauhini Vara\\'s writing reflects on disintegration, decay, and loss, emphasizing the\\nimpact of capitalism as she considers her work as \"living documents.\"',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:45.921496'},\n",
       "   {'id': 'web_407437e4',\n",
       "    'url': 'https://centerforfiction.org/interviews/an-interview-with-vauhini-vara-2022-first-novel-prize-finalist-for-the-immortal-king-rao/',\n",
       "    'title': 'An Interview with Vauhini Vara, 2022 First Novel Prize Finalist for ...',\n",
       "    'content': '**Vauhini Vara**, author of *The Immortal King Rao*, spoke with Celeste Kaufman, The Center’s Manager of Marketing and Public Relations, in celebration of being shortlisted for the 2022 First Novel Prize. Thank you for that really thoughtful question and reading because some people have read the book and said to me something along the lines of, “This is a Dalit character, this is a character who comes from the most oppressed class in India, isn’t it problematic that when he moves to the U.S. and finds success he replicates many of the oppressive class structures that he left behind in India?” But it was very intentional that I had this particular character who moves to the U.S. and gets an education and starts a company not try to break down these structures because it felt to me that the character who sees the structure that oppresses him and wants to dismantle it is not going to be the character who succeeds academically and professionally and financially.',\n",
       "    'excerpt': '**Vauhini Vara**, author of *The Immortal King Rao*, spoke with Celeste Kaufman, The Center’s Manager of Marketing and Public Relations, in celebration of being shortlisted for the 2022 First Novel Pr',\n",
       "    'two_line_summary': 'Vauhini Vara discusses her novel *The Immortal King Rao*, addressing critiques of its Dalit protagonist\\nwho, despite escaping oppression, replicates oppressive structures in the U.S. as a reflection of his success.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:47.943248'},\n",
       "   {'id': 'web_62d16b14',\n",
       "    'url': 'https://www.npr.org/2025/07/23/g-s1-78913/author-asks-chatgpt-for-advice-on-her-book-about-tech-heres-what-it-said',\n",
       "    'title': 'Author asks ChatGPT for advice on her book about tech - NPR',\n",
       "    'content': 'Let\\'s get back to my interview with tech journalist and fiction writer Vauhini Vara. Her new book, \"Searches: Selfhood In The Digital Age,\" is',\n",
       "    'excerpt': 'Let\\'s get back to my interview with tech journalist and fiction writer Vauhini Vara. Her new book, \"Searches: Selfhood In The Digital Age,\" is',\n",
       "    'two_line_summary': 'Tech journalist Vauhini Vara discusses her book \"Searches: Selfhood In The Digital Age,\" exploring the intersection\\nof technology and identity. She also shares insights from consulting ChatGPT for advice on her writing.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2025-07-23',\n",
       "    'age_days': 91,\n",
       "    'is_recent': True,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.6,\n",
       "    'reliability_reasons': ['recent within policy window'],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:50.096036'},\n",
       "   {'id': 'web_4f52791a',\n",
       "    'url': 'http://www.unclearmag.com/music-posts/2022/12/17/vara-interview',\n",
       "    'title': 'VARA: INTERVIEW - Unclear Magazine',\n",
       "    'content': 'by lauren kovolenko. photo courtesy of vara. Looking for someone interesting to read about this week? Meet Vara, an up-and-coming music',\n",
       "    'excerpt': 'by lauren kovolenko. photo courtesy of vara. Looking for someone interesting to read about this week? Meet Vara, an up-and-coming music',\n",
       "    'two_line_summary': 'Vara, an emerging music artist, shares insights in an interview with\\nLauren Kovolenko. Discover her journey and artistic vision in this engaging feature.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2022-12-17',\n",
       "    'age_days': 1040,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:51.932457'},\n",
       "   {'id': 'web_3c8b5fb5',\n",
       "    'url': 'https://medium.com/@VaraNetwork/vara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55',\n",
       "    'title': 'Vara Network: Pioneering the Future of Web 3.0 ...',\n",
       "    'content': '[Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&source=post_page---top_nav_layout_nav-----------------------global_nav------------------) [Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&source=post_page---top_nav_layout_nav-----------------------global_nav------------------) [![Image 2: Vara Network](https://miro.medium.com/v2/resize:fill:64:64/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---byline--b67abe3c8e55---------------------------------------) [](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fvote%2Fp%2Fb67abe3c8e55&operation=register&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&user=Vara+Network&userId=32229df92eb9&source=---header_actions--b67abe3c8e55---------------------clap_footer------------------) [](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fvote%2Fp%2Fb67abe3c8e55&operation=register&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&user=Vara+Network&userId=32229df92eb9&source=---footer_actions--b67abe3c8e55---------------------clap_footer------------------) [](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fvote%2Fp%2Fb67abe3c8e55&operation=register&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&user=Vara+Network&userId=32229df92eb9&source=---footer_actions--b67abe3c8e55---------------------clap_footer------------------) [![Image 8: Vara Network](https://miro.medium.com/v2/resize:fill:96:96/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---post_author_info--b67abe3c8e55---------------------------------------) [![Image 9: Vara Network](https://miro.medium.com/v2/resize:fill:128:128/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---post_author_info--b67abe3c8e55---------------------------------------) [What are your thoughts?](https://medium.com/m/signin?operation=register&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&source=---post_responses--b67abe3c8e55---------------------respond_sidebar------------------) [![Image 12: Vara Network](https://miro.medium.com/v2/resize:fill:20:20/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----0---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [Vara Network](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----0---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [From Code to Cosmos: Creating a Blockchain Game with AI on Vara --------------------------------------------------------------- ### How Vara’s developer tools and AI came together to create a playable on-chain shooter.](https://medium.com/@VaraNetwork/from-code-to-cosmos-creating-a-blockchain-game-with-ai-on-vara-808ec9895295?source=post_page---author_recirc--b67abe3c8e55----0---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [![Image 14: Vara Network](https://miro.medium.com/v2/resize:fill:20:20/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----1---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [Vara Network](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----1---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [![Image 16: Vara Network](https://miro.medium.com/v2/resize:fill:20:20/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----2---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [Vara Network](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----2---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [](https://medium.com/@VaraNetwork/building-a-vara-based-token-app-a-simple-guide-for-developers-using-react-and-vft-58359302c2a6?source=post_page---author_recirc--b67abe3c8e55----2---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fbookmark%2Fp%2F58359302c2a6&operation=register&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fbuilding-a-vara-based-token-app-a-simple-guide-for-developers-using-react-and-vft-58359302c2a6&source=---author_recirc--b67abe3c8e55----2-----------------bookmark_preview----530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [![Image 18: Vara Network](https://miro.medium.com/v2/resize:fill:20:20/1*MDIK2Uh8WrAFwbXdeRsurw.jpeg)](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----3---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [Vara Network](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55----3---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [From Ping to Pong: Cross-Chain App Dev with Vara & Ethereum ----------------------------------------------------------- ### Developers now have a live example of how two programs, running on separate blockchains, can exchange logic and data without having to…](https://medium.com/@VaraNetwork/from-ping-to-pong-cross-chain-app-dev-with-vara-ethereum-5252564d7651?source=post_page---author_recirc--b67abe3c8e55----3---------------------530867d8_6b5a_48cf_9c86_3b83a0666610--------------) [See all from Vara Network](https://medium.com/@VaraNetwork?source=post_page---author_recirc--b67abe3c8e55---------------------------------------) [](https://medium.com/@luckynautiyal/designing-the-blockchain-network-topology-ac898a255516?source=post_page---read_next_recirc--b67abe3c8e55----1---------------------779c20b9_28f5_4ce0_b388_438fc1d0fe1c--------------)',\n",
       "    'excerpt': '[Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2F%40VaraNetwork%2Fvara-network-pioneering-the-future-of-web-3-0-development-b67abe3c8e55&source=post_page---top',\n",
       "    'two_line_summary': 'Vara Network is advancing Web 3.0 development by providing innovative tools and AI integration for\\nblockchain applications. Their platform enables seamless cross-chain interactions and enhances the creation of decentralized applications.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:54.587508'},\n",
       "   {'id': 'web_8859fec7',\n",
       "    'url': 'https://medium.com/@VaraNetwork/about',\n",
       "    'title': 'About – Vara Network',\n",
       "    'content': 'Read writing from Vara Network on Medium. Vara is a fast and scalable Layer-1 decentralized network powered by Gear Protocol.',\n",
       "    'excerpt': 'Read writing from Vara Network on Medium. Vara is a fast and scalable Layer-1 decentralized network powered by Gear Protocol.',\n",
       "    'two_line_summary': 'Vara Network is a fast, scalable Layer-1 decentralized network utilizing\\nGear Protocol. Follow their Medium writings for insights and updates.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:56.532291'},\n",
       "   {'id': 'web_658d6fc0',\n",
       "    'url': 'https://medium.com/@VaraNetwork',\n",
       "    'title': 'Vara Network',\n",
       "    'content': 'Read writing from Vara Network on Medium. Vara is a fast and scalable Layer-1 decentralized network powered by Gear Protocol.',\n",
       "    'excerpt': 'Read writing from Vara Network on Medium. Vara is a fast and scalable Layer-1 decentralized network powered by Gear Protocol.',\n",
       "    'two_line_summary': 'Vara Network is a fast, scalable Layer-1 decentralized network\\nutilizing Gear Protocol. Follow their insights and updates on Medium.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:03:58.487964'},\n",
       "   {'id': 'web_f94f99be',\n",
       "    'url': 'https://medium.com/@VaraNetwork/vara-monthly-recap-august-2025-5f511358d316',\n",
       "    'title': 'Vara Monthly Recap | August 2025',\n",
       "    'content': 'Vara Network is a stand-alone layer-1 decentralized network built and running on top of Gear Protocol. Created by Gear Foundation, Vara aims to',\n",
       "    'excerpt': 'Vara Network is a stand-alone layer-1 decentralized network built and running on top of Gear Protocol. Created by Gear Foundation, Vara aims to',\n",
       "    'two_line_summary': 'Vara Network is a decentralized layer-1 network developed on Gear Protocol by Gear\\nFoundation. Its goal is to enhance blockchain capabilities and foster innovation within the ecosystem.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:00.484298'},\n",
       "   {'id': 'web_1a177e7c',\n",
       "    'url': 'https://medium.com/@VaraNetwork/vara-monthly-recap-july-2025-cb5fcb693cc4',\n",
       "    'title': 'Vara Monthly Recap | July 2025',\n",
       "    'content': 'Vara Network is a stand-alone layer-1 decentralized network built and running on top of Gear Protocol. Created by Gear Foundation, Vara aims to',\n",
       "    'excerpt': 'Vara Network is a stand-alone layer-1 decentralized network built and running on top of Gear Protocol. Created by Gear Foundation, Vara aims to',\n",
       "    'two_line_summary': 'Vara Network is a layer-1 decentralized network developed by Gear Foundation, designed to\\noperate on Gear Protocol. Its goal is to enhance blockchain capabilities and user experience.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:02.551351'},\n",
       "   {'id': 'web_78515a46',\n",
       "    'url': 'https://github.com/Vara-Lab',\n",
       "    'title': 'Vara Lab',\n",
       "    'content': 'Ecosystem Tooling for Vara Network. Vara Lab has 73 repositories available. Follow their code on GitHub.',\n",
       "    'excerpt': 'Ecosystem Tooling for Vara Network. Vara Lab has 73 repositories available. Follow their code on GitHub.',\n",
       "    'two_line_summary': 'Vara Lab offers ecosystem tooling for the Vara Network with 73 repositories\\navailable on GitHub. Users can follow their code and contributions through the platform.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:04.960535'},\n",
       "   {'id': 'web_8d18fc7a',\n",
       "    'url': 'https://github.com/se-sic/VaRA-Tool-Suite',\n",
       "    'title': 'se-sic/VaRA-Tool-Suite',\n",
       "    'content': 'VaRA is a variability-aware framework to analyze interactions between code regions that convey a semantic meaning for the researcher, e.g.,',\n",
       "    'excerpt': 'VaRA is a variability-aware framework to analyze interactions between code regions that convey a semantic meaning for the researcher, e.g.,',\n",
       "    'two_line_summary': 'VaRA is a framework designed to analyze interactions between code regions, focusing\\non their semantic meanings. It supports researchers in understanding variability in software systems.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:06.933080'},\n",
       "   {'id': 'web_3f2b145f',\n",
       "    'url': 'https://github.com/gear-foundation/vara-starship',\n",
       "    'title': 'gear-foundation/vara-starship',\n",
       "    'content': 'Contribute to gear-foundation/vara-starship development by creating an account on GitHub.',\n",
       "    'excerpt': 'Contribute to gear-foundation/vara-starship development by creating an account on GitHub.',\n",
       "    'two_line_summary': 'Join the gear-foundation/vara-starship project by creating a GitHub account to contribute\\nto its development. Engage with the community and enhance the project collaboratively.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:09.646789'},\n",
       "   {'id': 'web_fdf8420b',\n",
       "    'url': 'https://github.com/topics/vara',\n",
       "    'title': 'vara · GitHub Topics',\n",
       "    'content': 'StockEx is a cutting-edge DApp powered by Vara Network smart contracts that revolutionizes stock trading. With StockEx, you gain complete control over your',\n",
       "    'excerpt': 'StockEx is a cutting-edge DApp powered by Vara Network smart contracts that revolutionizes stock trading. With StockEx, you gain complete control over your',\n",
       "    'two_line_summary': 'StockEx is an innovative decentralized application utilizing Vara Network smart contracts to\\ntransform stock trading. It offers users full control over their trading activities.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:11.790108'},\n",
       "   {'id': 'web_84c7f149',\n",
       "    'url': 'https://github.com/Vara-Lab/standards',\n",
       "    'title': 'Vara-Lab/standards: Contract standards for Vara Network',\n",
       "    'content': 'Contract standards for Vara Network. Contribute to Vara-Lab/standards development by creating an account on GitHub.',\n",
       "    'excerpt': 'Contract standards for Vara Network. Contribute to Vara-Lab/standards development by creating an account on GitHub.',\n",
       "    'two_line_summary': \"Vara Network's contract standards are available for development on\\nGitHub. Users can contribute by creating an account with Vara-Lab.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:13.587301'},\n",
       "   {'id': 'web_a61bfd96',\n",
       "    'url': 'https://in.linkedin.com/company/varatechnology',\n",
       "    'title': 'Vara',\n",
       "    'content': \"Overview:\\nVara Group is dedicated to building futuristic platforms using technology and innovation to enhance businesses. We're proud innovators of some of the most revolutionizing solutions in the world of technology, infrastructure, cyber security, and many more.\\n\\nWebsite: https://varatechnology.com/\\nCrunchbase Url: N/A\\nLinkedin Url: https://www.linkedin.com/company/varatechnology\\n\\nIndustry:\\nIT Services and IT Consulting\\n\\nCompany size:\\n1,001-5,000 employees\\n577 associated members (LinkedIn members who’ve listed Vara as their current workplace on their profile)\\n\\nFounded:\\n2016\\n\\nFunding:\\nLast Round Date: N/A\\nLast Round Type: N/A\\nTotal Rounds: N/A\\nLast Round Raised: N/A\\n\\nInvestors:\\nN/A\",\n",
       "    'excerpt': \"Overview:\\nVara Group is dedicated to building futuristic platforms using technology and innovation to enhance businesses. We're proud innovators of some of the most revolutionizing solutions in the wo\",\n",
       "    'two_line_summary': 'Vara Group specializes in innovative technology solutions to enhance businesses, focusing on areas like infrastructure\\nand cybersecurity. Founded in 2016, it employs 1,001-5,000 people in the IT services and consulting industry.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:16.653708'},\n",
       "   {'id': 'web_4ec312cd',\n",
       "    'url': 'https://www.linkedin.com/company/vara-climate',\n",
       "    'title': 'Vara',\n",
       "    'content': 'Overview:\\nVara is an AI-powered environmental compliance software solution for manufacturers. Email us at Anandini@vara.eco to learn more!\\n\\nWebsite: https://www.vara.eco/\\nCrunchbase Url: N/A\\nLinkedin Url: https://www.linkedin.com/company/vara-climate\\n\\nIndustry:\\nSoftware Development\\n\\nCompany size:\\n1 employee\\n5 associated members (LinkedIn members who’ve listed Vara as their current workplace on their profile)\\n\\nFounded:\\nN/A\\n\\nFunding:\\nLast Round Date: N/A\\nLast Round Type: N/A\\nTotal Rounds: N/A\\nLast Round Raised: N/A\\n\\nInvestors:\\nN/A',\n",
       "    'excerpt': 'Overview:\\nVara is an AI-powered environmental compliance software solution for manufacturers. Email us at Anandini@vara.eco to learn more!\\n\\nWebsite: https://www.vara.eco/\\nCrunchbase Url: N/A\\nLinkedin ',\n",
       "    'two_line_summary': 'Vara is an AI-driven software solution focused on environmental compliance for\\nmanufacturers. For inquiries, contact Anandini@vara.eco or visit their website at www.vara.eco.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:18.793909'},\n",
       "   {'id': 'web_832b606f',\n",
       "    'url': 'https://ae.linkedin.com/company/varadubai',\n",
       "    'title': 'Virtual Assets Regulatory Authority [VARA]',\n",
       "    'content': \"Overview:\\nWelcome to VARA, the Virtual Assets Regulatory Authority of Dubai, where we stand at the forefront of responsible innovation by regulating, supervising, and overseeing virtual assets and related activities across Dubai. As the world's foremost independent regulator, VARA is dedicated to upholding customer protection and nurturing innovation within the dynamic landscape of virtual assets. We take considerable pride in serving as a transparent and trusted guiding authority. We invite you to connect with us for regular updates on Dubai's evolution as a hub for secure and innovative virtual assets.\\n\\nWebsite: https://www.vara.ae/en/\\nCrunchbase Url: N/A\\nLinkedin Url: https://www.linkedin.com/company/varadubai\\n\\nIndustry:\\nGovernment Administration\\n\\nCompany size:\\n51-200 employees\\n38 associated members (LinkedIn members who’ve listed Virtual Assets Regulatory Authority [VARA] as their current workplace on their profile)\\n\\nFounded:\\n2022\\n\\nFunding:\\nLast Round Date: N/A\\nLast Round Type: N/A\\nTotal Rounds: N/A\\nLast Round Raised: N/A\\n\\nInvestors:\\nN/A\",\n",
       "    'excerpt': 'Overview:\\nWelcome to VARA, the Virtual Assets Regulatory Authority of Dubai, where we stand at the forefront of responsible innovation by regulating, supervising, and overseeing virtual assets and rel',\n",
       "    'two_line_summary': \"VARA, Dubai's Virtual Assets Regulatory Authority, oversees and regulates virtual assets to ensure customer protection and foster\\ninnovation. Established in 2022, it aims to position Dubai as a leading hub for secure virtual assets.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:21.095546'},\n",
       "   {'id': 'web_4d5a190d',\n",
       "    'url': 'https://au.linkedin.com/company/vararesearch?trk=similar-pages_result-card_full-click',\n",
       "    'title': 'VARA',\n",
       "    'content': 'Vara Research GmbH is an independent service provider of external investor relations services. As a neutral source, our company delivers the necessary',\n",
       "    'excerpt': 'Vara Research GmbH is an independent service provider of external investor relations services. As a neutral source, our company delivers the necessary',\n",
       "    'two_line_summary': 'Vara Research GmbH offers independent external investor relations services, acting as a neutral source\\nfor essential information. The company focuses on enhancing communication between businesses and their investors.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:22.935365'},\n",
       "   {'id': 'web_91683afe',\n",
       "    'url': 'https://ca.linkedin.com/company/vara-platforms',\n",
       "    'title': 'VARA Platforms',\n",
       "    'content': 'VARA Platforms is a new Media company started in Silicon Valley North by 3 entrepreneurs who saw a need to change the overwrought advertising space.',\n",
       "    'excerpt': 'VARA Platforms is a new Media company started in Silicon Valley North by 3 entrepreneurs who saw a need to change the overwrought advertising space.',\n",
       "    'two_line_summary': 'VARA Platforms, founded by three entrepreneurs in Silicon Valley North, aims to innovate the\\nsaturated advertising industry. The company seeks to address the challenges within the current media landscape.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:24.804668'},\n",
       "   {'id': 'web_cedf5055',\n",
       "    'url': 'https://www.vara.ai/press-releases/vara-raises-8-9m-expands-ai-breast-cancer-detection-india',\n",
       "    'title': 'Vara Raises $8.9M in Funding While Expanding AI-Enabled Early ...',\n",
       "    'content': \"### Vara Raises $8.9M in Funding While Expanding AI-Enabled Early Breast Cancer Detection to India Vara, the pioneering AI-enabled early breast cancer detection platform, today announced the successful funding raise of $8.9 million USD (€8M EUR), which took place earlier this year. “By combining an AI-driven screening approach with proven medical evidence and commercialization in emerging markets, Vara is an excellent fit for the goals of our impact fund,” said Ute Mercker, Investment Director at IBB Ventures. Headquartered in Berlin, Germany with offices in India, Vara's AI-powered software enhances accuracy and efficiency in breast cancer detection, identifying 43% more cancers that radiologists might miss while reducing their workload by up to 73%.\",\n",
       "    'excerpt': '### Vara Raises $8.9M in Funding While Expanding AI-Enabled Early Breast Cancer Detection to India Vara, the pioneering AI-enabled early breast cancer detection platform, today announced the successfu',\n",
       "    'two_line_summary': \"Vara has raised $8.9 million to expand its AI-driven breast cancer detection platform in India, enhancing accuracy\\nand efficiency while significantly reducing radiologists' workload. The funding aligns with the goals of IBB Ventures' impact fund.\",\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:27.078579'},\n",
       "   {'id': 'web_cba87d7e',\n",
       "    'url': 'https://hitconsultant.net/2024/10/29/vara-ai-powered-breast-cancer-screening-funding/',\n",
       "    'title': 'Vara Raises $8.9M for AI-Powered Breast Cancer Screening',\n",
       "    'content': 'Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.',\n",
       "    'excerpt': 'Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.',\n",
       "    'two_line_summary': 'Vara, a Berlin-based company specializing in AI-driven breast cancer detection, has secured $8.9 million\\nin a Series B funding round. This investment aims to enhance their innovative screening technology.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2024-10-29',\n",
       "    'age_days': 358,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:28.874046'},\n",
       "   {'id': 'web_a6728eae',\n",
       "    'url': 'https://news.merantix-capital.com/p/varas-explosive-new-study-on-ais',\n",
       "    'title': \"Vara's explosive new study on AI's power in combating breast cancer\",\n",
       "    'content': 'Furthermore, on Tuesday, Vara announced that it has raised an additional funding round of $8.9 million USD (€8M EUR), which it will use to',\n",
       "    'excerpt': 'Furthermore, on Tuesday, Vara announced that it has raised an additional funding round of $8.9 million USD (€8M EUR), which it will use to',\n",
       "    'two_line_summary': 'Vara has secured $8.9 million in new funding to advance its initiatives.\\nThe announcement coincides with the release of a significant study on artificial intelligence.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:31.063317'},\n",
       "   {'id': 'web_713d2f8e',\n",
       "    'url': 'https://tech.eu/2024/10/29/vara-s-raises-8-9m-for-its-ai-powered-mammogram-screening-platform/',\n",
       "    'title': 'Vara raises $8.9M for its AI-powered mammogram screening platform',\n",
       "    'content': \"+ Tech.eu Insights # Vara raises $8.9M for its AI-powered mammogram screening platform Today, nearly 40 per cent of breast cancer screening in Germany is managed on Vara's AI platform AI-enabled early breast cancer detection platform Vara today announced a $8.9 million fundraise. Founded in 2018 by Jonas Muff, CEO, and Stefan Bunk, CTO, Vara's AI-powered software enhances accuracy and efficiency in breast cancer detection. The software is integrated into Germany's National Breast Cancer Screening Program, Vara supports 40 per cent of the country's screening centres, the only AI system deployed at scale in the program, benefiting over 80,000 women monthly. Vara raises $8.9M for its AI-powered mammogram screening platform\",\n",
       "    'excerpt': \"+ Tech.eu Insights # Vara raises $8.9M for its AI-powered mammogram screening platform Today, nearly 40 per cent of breast cancer screening in Germany is managed on Vara's AI platform AI-enabled early\",\n",
       "    'two_line_summary': 'Vara has raised $8.9 million for its AI-driven mammogram screening platform, which currently supports 40% of\\nbreast cancer screenings in Germany. The technology enhances detection accuracy and serves over 80,000 women monthly.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': '2024-10-29',\n",
       "    'age_days': 358,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:34.162551'},\n",
       "   {'id': 'web_de7418fe',\n",
       "    'url': 'https://www.thesaasnews.com/news/vara-raises-8-9-million-in-funding',\n",
       "    'title': 'Vara Raises $8.9 Million in Funding | The SaaS News',\n",
       "    'content': \"# Vara Raises $8.9 Million in Funding Vara, a Berlin, Germany-based AI-powered breast cancer detection platform, has raised $8.9 million in funding. The round was led by new investors, including Austria's Smart Family Office, Germany's FJH, and Berlin\\x80\\x99s IBB Ventures. Backed by Investitionsbank Berlin and the ERDF, IBB Ventures has invested over \\x82¬275 million in more than 260 Berlin-based companies, catalyzing a total of \\x82¬1.8 billion in funding alongside partners. **Vara Use of Funds** Founded in 2018 by Jonas Muff and Stefan Bunk, Vara is a healthcare technology company specializing in AI-powered breast cancer screening. Vara's AI-powered software enhances accuracy and efficiency in breast cancer detection, identifying more cancers that radiologists might miss while reducing their workload. Source: https://www.globenewswire.com/news-release/2024/10/29/2970678/0/en/Vara-Raises-8-9M-in-Funding-While-Expanding-AI-Enabled-Early-Breast-Cancer-Detection-to-India.html\",\n",
       "    'excerpt': '# Vara Raises $8.9 Million in Funding Vara, a Berlin, Germany-based AI-powered breast cancer detection platform, has raised $8.9 million in funding. The round was led by new investors, including Austr',\n",
       "    'two_line_summary': 'Vara, an AI-driven breast cancer detection platform based in Berlin, has secured $8.9 million in funding\\nfrom various investors. The funds will enhance its technology and expand its services, including plans for India.',\n",
       "    'source_type': 'secondary',\n",
       "    'source_category': 'news',\n",
       "    'publisher': None,\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 9999,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'medium',\n",
       "    'reliability_score': 0.5,\n",
       "    'reliability_reasons': [],\n",
       "    'evidence_tier': 'tier2',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'web_collection',\n",
       "    'collected_at': '2025-10-22T20:04:36.420102'}],\n",
       "  'count': 50,\n",
       "  'sources': ['news'],\n",
       "  'sources_breakdown': {'news': 50},\n",
       "  'primary_sources_count': 0,\n",
       "  'secondary_sources_count': 50,\n",
       "  'newest_date': '2025-10-22',\n",
       "  'oldest_date': '2022-12-17',\n",
       "  'recent_documents_count': 5,\n",
       "  'high_reliability_count': 0,\n",
       "  'medium_reliability_count': 50,\n",
       "  'low_reliability_count': 0,\n",
       "  'average_reliability': 0.51,\n",
       "  'gate': {'passed': False,\n",
       "   'missing_slots': ['diversity', 'primary', 'reliability'],\n",
       "   'reasons': ['1차 출처 부족 0/2', '평균 신뢰도 낮음 0.51 < 0.60', '카테고리 다양성 부족 1/2']},\n",
       "  'attempts': {'current': 1, 'max': 1},\n",
       "  'decision_log': [{'attempt': 1,\n",
       "    'queries': ['Vara medical company overview',\n",
       "     'Vara product features technology',\n",
       "     'Vara news press release',\n",
       "     'Vara case study',\n",
       "     'Vara whitepaper',\n",
       "     'Vara interview',\n",
       "     'Vara site:medium.com',\n",
       "     'Vara site:github.com',\n",
       "     'Vara site:linkedin.com',\n",
       "     'Vara funding announcement'],\n",
       "    'new_docs': 50,\n",
       "    'total_docs': 50,\n",
       "    'gate_passed': False,\n",
       "    'missing_slots': ['diversity', 'primary', 'reliability'],\n",
       "    'reasons': ['1차 출처 부족 0/2', '평균 신뢰도 낮음 0.51 < 0.60', '카테고리 다양성 부족 1/2'],\n",
       "    'timestamp': '2025-10-22T20:04:36.436051'}],\n",
       "  'threshold_profile': {'min_docs': 50,\n",
       "   'min_primary': 2,\n",
       "   'recent_window_days': 180,\n",
       "   'min_recent': 3,\n",
       "   'avg_rel_min': 0.6,\n",
       "   'low_ratio_max': 0.3,\n",
       "   'distinct_domains_min': 4,\n",
       "   'category_diversity_min': 2,\n",
       "   'max_attempts': 1},\n",
       "  'error': None},\n",
       " 'specialized_collection': {'status': 'completed',\n",
       "  'documents': [{'id': 'spec_f68c54db',\n",
       "    'url': 'https://arxiv.org/pdf/2403.15442?',\n",
       "    'title': 'Artificial Intelligence for Cochlear Implants: Review of ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'to demographics, audiometric data, and patient-reported outcomes. The results showed that the neural network model achieved a 1-year postoperative performance prediction root mean square error (RMSE) ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:38.345906'},\n",
       "   {'id': 'spec_bb2862c5',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': 'The imperative for AI in medical imaging to prioritize interpretability, robustness and trustworthiness, rather than raw accuracy alone, naturally aligns with human-in-the-loop (HITL) machine learning',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:38.345906'},\n",
       "   {'id': 'spec_bbc83f95',\n",
       "    'url': 'https://arxiv.org/pdf/2504.05483?',\n",
       "    'title': 'arXiv:2504.05483v1 [cs.CV] 7 Apr 2025',\n",
       "    'content': None,\n",
       "    'excerpt': 'The imperative for AI in medical imaging to prioritize interpretability, robustness and trustworthi-ness, rather than raw accuracy alone, naturally aligns with human-in-the-loop (HITL) machine learnin',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:38.345906'},\n",
       "   {'id': 'spec_34f5b554',\n",
       "    'url': 'https://arxiv.org/html/2501.01157v1',\n",
       "    'title': 'Ultrasound Lung Aeration Map via Physics-Aware Neural ...',\n",
       "    'content': None,\n",
       "    'excerpt': '| Simulation Set | Ex-vivo Set |\\n --- |\\n| Training | Validation | Evaluation | Sum | Fine-Tuning | Evaluation | Sum |\\n| Number of data samples | 10,150 | 1,450 | 2,900 | 14,500 | 18 | 103 | 121 |\\n| Ch',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:38.345906'},\n",
       "   {'id': 'spec_2f46ea33',\n",
       "    'url': 'https://arxiv.org/pdf/2307.08411',\n",
       "    'title': '(PDF) Neurosymbolic AI for Reasoning on Biomedical ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'A more prominent challenge in ML-based biomedical stud-ies, including those within this survey, is drug reposi-tioning, or repurposing (DR). DR is the use of a clini-cally approved drug to treat anoth',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:38.345906'},\n",
       "   {'id': 'spec_fc933992',\n",
       "    'url': 'https://arxiv.org/pdf/2303.05606',\n",
       "    'title': 'Variance-aware robust reinforcement learning with linear ...',\n",
       "    'content': None,\n",
       "    'excerpt': '4 Variance Aware Regret for Linear MDPs 4.1 High-level Algorithm Description In this section, we present VARA, an algorithm collected in Algorithm 2, that extends AdaO-FUL to solve linear MDPs with he',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:39.475740'},\n",
       "   {'id': 'spec_6d13d846',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': 'Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul.\\n  Deep learning in medical imaging: Image processing - from augmenting accuracy to enhancing efficiency.\\n ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:39.475740'},\n",
       "   {'id': 'spec_d3b78621',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/35750400/',\n",
       "    'title': 'Combining the strengths of radiologists and AI for breast ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Funding: Vara.\\n\\nCopyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.\\n\\nPubMed Disclaim',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:39.475740'},\n",
       "   {'id': 'spec_92821fe2',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/36572053/',\n",
       "    'title': 'Endometrial Cancer Individualised Scoring System (ECISS)',\n",
       "    'content': None,\n",
       "    'excerpt': 'Sherif A Shazly1,Pluvio J Coronado2,Ercan Yılmaz3,Rauf Melekoglu3,Hanifi Sahin3,Luca Giannella4,Andrea Ciavattini4,Giovanni Delli Carpini4,Jacopo Di Giuseppe4,Angel Yordanov5,Konstantina Karakadieva5,',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:39.475740'},\n",
       "   {'id': 'spec_7828fff3',\n",
       "    'url': 'https://arxiv.org/pdf/2408.13284',\n",
       "    'title': 'Assessing Latent Dirichlet Allocation in Training Neural ...',\n",
       "    'content': None,\n",
       "    'excerpt': \"and, therefore, introduced a manual review process to estimate the method's true performance. We achieved considerably better results than Shin et al. for CNN on some labels, but we also had more imag\",\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:39.475740'},\n",
       "   {'id': 'spec_d963d2a2',\n",
       "    'url': 'https://arxiv.org/html/2406.04068v1',\n",
       "    'title': 'Reassessing How to Compare and Improve the Calibration ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Nogales et al. (2021)  Nogales, A., Álvaro J. García-Tejedor, Monge, D., Vara, J. S., and Antón, C.  A survey of deep learning models in medical therapeutic areas.  Artificial Intelligence in Medicine',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:40.677232'},\n",
       "   {'id': 'spec_44960a3e',\n",
       "    'url': 'https://arxiv.org/pdf/2504.05483',\n",
       "    'title': 'arXiv:2504.05483v1 [cs.CV] 7 Apr 2025',\n",
       "    'content': None,\n",
       "    'excerpt': 'arXiv preprint arXiv:1905.04172 , 2019. 4  Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul. Deep learn-ing in medical imaging: Image processing - from aug-',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:40.677232'},\n",
       "   {'id': 'spec_7bd23e82',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': 'Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul.\\n  Deep learning in medical imaging: Image processing - from augmenting accuracy to enhancing efficiency.\\n ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:40.677232'},\n",
       "   {'id': 'spec_9b79ebcc',\n",
       "    'url': 'https://arxiv.org/pdf/2307.06162',\n",
       "    'title': 'Deep Generative Models for Physiological Signals',\n",
       "    'content': None,\n",
       "    'excerpt': 'G. Monachino, B. Zanchi, L. Fiorillo, G. Conte, A. Auricchio, A. Tzo-vara, F. D. Faraci, Deep Generative Models: The winning key for large and easily accessible ECG datasets?, Computers in biology and',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:40.677232'},\n",
       "   {'id': 'spec_75dd5ee5',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/33581832/',\n",
       "    'title': 'A survey of deep learning models in medical therapeutic ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'select the papers obtained after the second screening. Finally, 126 studies from the initial 3493 papers were selected and 64 were described. Results show that the number of publications on deep learn',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:40.677232'},\n",
       "   {'id': 'spec_2c5b9f21',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/19352233/',\n",
       "    'title': 'Acute versus gradual correction of idiopathic tibia vara in ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Idiopathic tibia vara (Blount disease) is an acquired form of tibial deformity found mainly in children who are Afro-Caribbean and obese. It is uncommon. Several methods have been described for the su',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:41.897518'},\n",
       "   {'id': 'spec_d80e3cf2',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/35750400/',\n",
       "    'title': 'Combining the strengths of radiologists and AI for breast ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Declaration of interests CL, MB, SB, and DB are employees of Vara, the funder of the study. LU is a medical advisor for Vara (MX Healthcare), a speaker and advisory board member for Bayer Healthcare, ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:41.897518'},\n",
       "   {'id': 'spec_f3d75ee4',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/33632009/',\n",
       "    'title': 'Tibia vara in Asians: Myth or fact? Verification with three- ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'The mean MPTA was 87.0° ± 2.2° (mean ± SD) when rotationally aligned to TCAx and 91.6° ± 2.7° when aligned to tmAx. The mean diaphyseal bowing was 0.1° ± 1.9° varus when rotationally aligned to TCAx a',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:41.897518'},\n",
       "   {'id': 'spec_5f46864f',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/3429646/',\n",
       "    'title': 'Infantile tibia vara',\n",
       "    'content': None,\n",
       "    'excerpt': 'osteotomies gave good results between 4 and 8 years of age. One-half of tibiae treated with osteotomy developed recurrent varus. This review documents earlier stages at presentation, a more malignant ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:41.898242'},\n",
       "   {'id': 'spec_6331bd91',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': 'Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul.\\n  Deep learning in medical imaging: Image processing - from augmenting accuracy to enhancing efficiency.\\n ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:41.898242'},\n",
       "   {'id': 'spec_b44ae9be',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/40816413/',\n",
       "    'title': 'Effect of remodeling on correction of tibia vara using the ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'This retrospective study included 18 patients with tibial varus deformity as a sequela of adolescent tibia vara who underwent proximal tibial deformity correction using the Hexapod External Fixator be',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:43.002544'},\n",
       "   {'id': 'spec_fdf4fd87',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/40861234/',\n",
       "    'title': 'Clinical outcomes of limited open reduction and ...',\n",
       "    'content': None,\n",
       "    'excerpt': '1, 3, and 6 months), and complication rates (coxa vara, implant failure, infection, deep vein thrombosis) were compared. Statistical analyses were performed using SPSS 26.0, with a significance thresh',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:43.003552'},\n",
       "   {'id': 'spec_217fc319',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/40963115/',\n",
       "    'title': 'Acute medial tibial plateau elevation with gradual ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'and all were treated conservatively. Varus deformity recurred in 5 (20.8%) patients, all at the metaphyseal level, with no collapse at the elevated medial tibial plateau. Significant Leg length discre',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:43.003552'},\n",
       "   {'id': 'spec_ac1bb717',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/38692292/',\n",
       "    'title': 'Recombinant ADAMTS13 in Congenital Thrombotic ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Collaborators, Affiliations  Expand \\n\\n### Collaborators\\n\\n   cTTP Phase 3 Study Investigators: Paul Knöbl,Claire Berger,Nathalie Biebuyck,Paul Coppo,Claire Dossier,Wolf-Achim Hassenpflug,Karim Kentouch',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:43.003552'},\n",
       "   {'id': 'spec_b5ffa6ee',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': '| NIG  | 20.57 | 45.74 | 57.31 | 91.36 | 18.01 | 47.69 | 62.99 | 93.95 | 20.85 | 47.99 | 64.08 | 97.53 |\\n| Rivisitng  | 26.30 | 52.36 | 65.87 | 94.79 | 31.61 | 58.53 | 68.02 | 94.14 | 33.28 | 60.88 | ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:43.003552'},\n",
       "   {'id': 'spec_e9b8d620',\n",
       "    'url': 'https://arxiv.org/html/2504.05483v1',\n",
       "    'title': 'Adversarial Robustness Meets Clinical Interpretability',\n",
       "    'content': None,\n",
       "    'excerpt': 'Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul.\\n  Deep learning in medical imaging: Image processing - from augmenting accuracy to enhancing efficiency.\\n ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:44.143480'},\n",
       "   {'id': 'spec_f12b6624',\n",
       "    'url': 'https://arxiv.org/html/2501.01157v1',\n",
       "    'title': 'Ultrasound Lung Aeration Map via Physics-Aware Neural ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Park, S. & Yoo, Y.   A new fast logarithm algorithm using advanced exponent bit extraction for software-based ultrasound imaging systems.   Electronics 12 (2023).   URL .\\n   Vara, G. et al.   Texture ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:44.143480'},\n",
       "   {'id': 'spec_d3990796',\n",
       "    'url': 'https://arxiv.org/pdf/2504.05483',\n",
       "    'title': 'arXiv:2504.05483v1 [cs.CV] 7 Apr 2025',\n",
       "    'content': None,\n",
       "    'excerpt': 'arXiv preprint arXiv:1905.04172 , 2019. 4  Lakshmi Vara Prasad G, Murali A, Bhaskar Reddy Y V, Haribabu Marturi, and Valeru Vision Paul. Deep learn-ing in medical imaging: Image processing - from aug-',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:44.143480'},\n",
       "   {'id': 'spec_1ff3d772',\n",
       "    'url': 'https://arxiv.org/pdf/2408.13284',\n",
       "    'title': 'Assessing Latent Dirichlet Allocation in Training Neural ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'label gave three possible outcomes: true, false, and missing. Labels for each anatomy were merged into labels for the data. Whenever there was no information, the outcome was set to missing. This was ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:44.143480'},\n",
       "   {'id': 'spec_67726011',\n",
       "    'url': 'https://arxiv.org/pdf/2307.08411',\n",
       "    'title': '(PDF) Neurosymbolic AI for Reasoning on Biomedical ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Ng, S. K., Krishnan, T., and McLachlan, G. J. The em algorithm. In Handbook of computational statistics, pp.\\n139–172. Springer, 2012.\\nNickel, M., Murphy, K., Tresp, V., and Gabrilovich, E.\\nA review of',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:44.143480'},\n",
       "   {'id': 'spec_c27a8222',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/40816413/',\n",
       "    'title': 'Effect of remodeling on correction of tibia vara using the ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'This retrospective study included 18 patients with tibial varus deformity as a sequela of adolescent tibia vara who underwent proximal tibial deformity correction using the Hexapod External Fixator be',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:45.315348'},\n",
       "   {'id': 'spec_8d7ed747',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/19292167/',\n",
       "    'title': 'A Retrospective Analysis of Treatment and Outcomes in ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'This retrospective analysis included 36 patients who presented with late-onset tibia vara during a 15-year period. Mean patient age at presentation was 12.8 years. Seventy-eight percent of patients we',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:45.315348'},\n",
       "   {'id': 'spec_d2632623',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/34384413/',\n",
       "    'title': 'Acute correction of severe complex adolescent late-onset ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Methods:\\nThis study was conducted between November 2016 and July 2020. We retrospectively reviewed the clinical notes and radiographs of 30 patients (32 tibiae) who had correction of severe late-onset',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:45.315348'},\n",
       "   {'id': 'spec_707c04d3',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/38047570/',\n",
       "    'title': \"Outcomes of late-stages infantile Blount's disease ...\",\n",
       "    'content': None,\n",
       "    'excerpt': 'This study aimed to evaluate the clinical and radiological outcomes of surgical intervention involving acute medial hemi-plateau elevation and metaphyseal osteotomy with internal fixation and growth m',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:45.315348'},\n",
       "   {'id': 'spec_6f76ec39',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/34766556/',\n",
       "    'title': 'Intertrochanteric valgus osteotomy for post-traumatic coxa ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'To investigate the clinical effects of a new intertrochanteric valgus osteotomy technique designed by the authors for treatment of post-traumatic coxa varus after proximal femur fractures. Retrospecti',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:45.315348'},\n",
       "   {'id': 'spec_6f8d9b3f',\n",
       "    'url': 'https://arxiv.org/pdf/2410.24128?',\n",
       "    'title': 'Q-learning for Quantile MDPs',\n",
       "    'content': None,\n",
       "    'excerpt': 'To this aim, we compare the performance of Algorithm 1 with other risk-averse algorithms. As a standard baseline, we include the risk-neutral objective (E). Other baselines are nested VaR (nVaR) (Rusz',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:46.603888'},\n",
       "   {'id': 'spec_9059544e',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/31856811/',\n",
       "    'title': 'Fast read alignment with incorporation of known genomic ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Conclusions:\\nDue to its efficiency, VARA provides a promising solution for further improvement of variant calling while maintaining small memory footprints. The deBGA-VARA is available at: \\n\\nKeywords:',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'PubMed',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:46.603888'},\n",
       "   {'id': 'spec_c4fe061b',\n",
       "    'url': 'https://arxiv.org/pdf/2506.02841',\n",
       "    'title': 'Enhancing Sample Efficiency in Multi-Agent RL Using ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Vara1∼π1,...,ak∼πk[λ1Qϕ1 1 (τ1, a1) + ... + λkQϕk k (τk, ak)]. [...] variance on the entire system through the centralized critic, disrupting the training process of the other agents. The focus of thi',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:46.603888'},\n",
       "   {'id': 'spec_569211f3',\n",
       "    'url': 'https://arxiv.org/pdf/2108.08612',\n",
       "    'title': 'Settling the Variance of Multi-Agent Policy Gradients',\n",
       "    'content': None,\n",
       "    'excerpt': 'Proof sketch. (For the full proof see Appendix B.2.) We start the proof by ﬁxing a state s and consider-ing the difference of Vara∼πθ[ ˆ Q(s, a−i, ai)∇θi log πi θ(ai|s)]−Varai∼πi θ[ ˆ Qi(s, ai)∇θi log',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:46.603888'},\n",
       "   {'id': 'spec_a05d0d83',\n",
       "    'url': 'https://arxiv.org/pdf/2507.19555',\n",
       "    'title': 'A Theoretical Framework for Robotic Reinforcement Learning',\n",
       "    'content': None,\n",
       "    'excerpt': 'Es∼ρπi[Vara∼πi[a|s]] is the average action variance • DKL(πi||πref) is the KL divergence from a reference policy We apply k-means clustering to group policies based on these features: Gk = {i : arg mi',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'academic',\n",
       "    'publisher': 'arXiv',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.9,\n",
       "    'reliability_reasons': ['학술 논문', '동료 검토'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:46.603888'},\n",
       "   {'id': 'spec_54394e45',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161155.pdf',\n",
       "    'title': '001_Origin Coxa Vara Hip 510k Application',\n",
       "    'content': None,\n",
       "    'excerpt': \"Sincerely yours, Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure Mark N. Melkerson -S \\x03\\x04/ \\x18\\x06\\x05\\x0e\\x02'\\x05\\x18\\x1b\\t& \\x0e\\x0b\\x04)\\x07\\x02\\x1a\",\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:47.833691'},\n",
       "   {'id': 'spec_8fdf9226',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232371.pdf',\n",
       "    'title': 'October 19, 2023 implantcast, GmbH Juliane Hoppner ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Device Description: The purpose of this Traditional 510(k) is to introduce into interstate commerce in the United States the Actinia® hip stems. The Actinia® hip stems are femoral stems for total or h',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:47.833691'},\n",
       "   {'id': 'spec_d20b9ddc',\n",
       "    'url': 'https://trade.ec.europa.eu/access-to-markets/et/content/masinad-ja-tehnilised-tooted',\n",
       "    'title': 'Masinad ja tehnilised tooted | Access2Markets',\n",
       "    'content': None,\n",
       "    'excerpt': 'The CE mark shall be followed by the two last digits of the year in which it was first affixed, the name and the registered address of the manufacturer, or the identifying mark allowing identification',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:47.833691'},\n",
       "   {'id': 'spec_2afc896d',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240528.pdf',\n",
       "    'title': 'November 15, 2024 b-ONE Ortho, Corp. Allison Gecik Director ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Collarless/Collared Coxa Vara families and Cemented Standard and Proportional Offset families. [...] is classified (see above) into either class II (Special Controls) or class III (PMA), it may be sub',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:47.833691'},\n",
       "   {'id': 'spec_6f2897ac',\n",
       "    'url': 'https://www.accessdata.fda.gov/CDRH510K/K130210.pdf',\n",
       "    'title': 'K130210.pdf - accessdata.fda.gov',\n",
       "    'content': None,\n",
       "    'excerpt': '..................\\n..................\\n..................\\n..................\\nement .........\\nport ...........\\n..................\\n..................\\n..................\\n..................\\n...............',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:47.833691'},\n",
       "   {'id': 'spec_5d53be36',\n",
       "    'url': 'https://health.ec.europa.eu/document/download/b45335c5-1679-4c71-a91c-fc7a4d37f12b_en',\n",
       "    'title': 'MDR and Regulation (EU) 2017/746 – IV',\n",
       "    'content': None,\n",
       "    'excerpt': 'the first time for its intended purpose;13 Medical device: “medical device” means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufactur',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:48.919023'},\n",
       "   {'id': 'spec_dc28675e',\n",
       "    'url': 'https://health.ec.europa.eu/document/download/b23b362f-8a56-434c-922a-5b3ca4d0a7a1_en',\n",
       "    'title': 'MDCG 2019-16 Rev.1 - Public Health - European Commission',\n",
       "    'content': None,\n",
       "    'excerpt': '# 1. Introduction \\n\\n## 1.1. Background \\n\\nThe two new Regulations on medical devices 745/2017 (MDR) and 746/2017 ( IV DR) (hereafter \\n\\ncalled the M edical Devices Regulations) have been adopted and ent',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:48.919023'},\n",
       "   {'id': 'spec_15fd5e3b',\n",
       "    'url': 'https://health.ec.europa.eu/system/files/2020-09/md_mdcg_2020_1_guidance_clinic_eva_md_software_en_0.pdf',\n",
       "    'title': 'MDCG 2020-1 Guidance on Clinical Evaluation (MDR ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'the safety or performance of a device. Source: EU 2017/745 (MDR), Article 2 (45) CLINICAL PERFORMANCE Article 2 (52) MDR defines clinical performance as the ability of a device, resulting from any dir',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:48.920063'},\n",
       "   {'id': 'spec_f7f0a6cc',\n",
       "    'url': 'https://health.ec.europa.eu/system/files/2020-09/md_mdcg_2018_5_software_en_0.pdf',\n",
       "    'title': 'MDCG 2018-5 - Public Health - European Commission',\n",
       "    'content': None,\n",
       "    'excerpt': 'Regulation (EU) 2017/745 (MDR) and the In-Vitro Diagnostic Medical Device Regulation (EU) 2017/746 (IVDR), only software which is commercially available on its own as well as software which constitute',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:48.920063'},\n",
       "   {'id': 'spec_dec5207d',\n",
       "    'url': 'https://health.ec.europa.eu/document/download/b865d8e9-081a-4601-a91a-f120321c0491_en',\n",
       "    'title': 'Medical Device?',\n",
       "    'content': None,\n",
       "    'excerpt': 'Regulation (EU) 2017/745 on Medical Devices (MDR) and Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR) MDSW according to  the definition of MDCG 2019-11 \\n\\n# 1. 2. 3. \\n\\nDoes the M',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:48.920063'},\n",
       "   {'id': 'spec_7d3f1c6d',\n",
       "    'url': 'https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K192189',\n",
       "    'title': '510(k) Premarket Notification - FDA',\n",
       "    'content': None,\n",
       "    'excerpt': '| |  |  |  --- | | Device Classification Name | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented | | 510(k) Number | K192189 | | Device Name | Avenir Comple',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:50.008075'},\n",
       "   {'id': 'spec_72e2b187',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161155.pdf',\n",
       "    'title': '001_Origin Coxa Vara Hip 510k Application',\n",
       "    'content': None,\n",
       "    'excerpt': 'Regulatory Class: Class II Product Code: MEH, KWZ Dated: April 21, 2016 Received: April 25, 2016 Dear Dr. Brazil: We have reviewed your Section 510(k) premarket notification of intent to market the de',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:50.008075'},\n",
       "   {'id': 'spec_67d34cb9',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192189.pdf',\n",
       "    'title': 'December 18, 2019 Zimmer, Inc. Neha Sreenath Senior ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Legally Marketed Reference Device used to support Substantial Equivalence: K120030 (cleared 08/17/2012) Taperloc Complete Size 4mm and XR 123° Biomet Manufacturing Corp. K192189 Page 1 of 4 K192189 Pu',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:50.008075'},\n",
       "   {'id': 'spec_b3f9e9b6',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf6/K060635.pdf',\n",
       "    'title': 'I6f Section 9 510(k) Summary of Safety and ... - accessdata.fda.gov',\n",
       "    'content': None,\n",
       "    'excerpt': '· Revision of failed femoral head replacement, cup arthroplasty or other hip procedures.\\n* Proximal femoral fractures * Avascular necrosis of the femoral head * Non-union of proximal femoral neck frac',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:50.008075'},\n",
       "   {'id': 'spec_1e3bc1fa',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233476.pdf',\n",
       "    'title': 'February 8, 2024 Orchard Medical Development Justin ...',\n",
       "    'content': None,\n",
       "    'excerpt': '0, 1, 2, 3, 4, 5, 6, 6.5, 7, 7.5, 8, 8.5, 9 Collar Collared, Collarless Collared, Collarless Page 3 of 4 Device Characteristic Subject Device Orchard Medical Z1 Hip Stem Primary Predicate Device Zimme',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:50.008075'},\n",
       "   {'id': 'spec_8373368a',\n",
       "    'url': 'https://trade.ec.europa.eu/access-to-markets/et/content/masinad-ja-tehnilised-tooted',\n",
       "    'title': 'Masinad ja tehnilised tooted | Access2Markets',\n",
       "    'content': None,\n",
       "    'excerpt': 'Before being placed on the EU market, products covered by Directive 2009/48/EC (CELEX 32009L0048) must bear the CE marking in order to attest that they comply with applicable essential requirements. T',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:51.216264'},\n",
       "   {'id': 'spec_938c639e',\n",
       "    'url': 'https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/product-management-services-pms-implementation-international-organization-standardization-iso-standards-identification-medicinal-products-idmp-europe-chapter-2-tracked-changes_en.pdf',\n",
       "    'title': 'Product Management Services (PMS) - Implementation of ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'medicinal product CAPs: Centralised Authorised Products. CE: Certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the Europ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:51.216264'},\n",
       "   {'id': 'spec_7b6ddc52',\n",
       "    'url': 'https://health.ec.europa.eu/document/download/37879254-c7d6-487b-8fd9-06496e771465_en',\n",
       "    'title': 'Authorised Representatives, Importers and Distributors',\n",
       "    'content': None,\n",
       "    'excerpt': 'và`ºÈqÕs´H¼\\xad8çcÀ·Kº\\x99|kzÔ /Ò\\x97ØIms\\x7fàSz ±ävµaõ\\\\\\x9ceõO}+<£ÆW4+n\\x9c~,¶É\\\\\\x7fÚÀA\\x81 æ¡,t¸\\xadLFÛZ;;Þ\\x8døá xÇt\\x801\\x97\\x91\\x9bÊÛP>Å b\\\\¸:À´mË\\x80T5498V\\xad²8�£K\\x8b®#o¬J\\x9fSxÒ°Ùzñ¹9BO -eì\\x9b¢nG²\\x95:GÛ\\x97\\x87:&ÍM´\\x9a®ÉÊkÆ776 Ñëa¾»zøxñH´ÅÊ\\x9aõ\\x8aI9W\\x84\\\\_c½Ò:0¾¢ËÍ',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:51.216264'},\n",
       "   {'id': 'spec_4aaeefb0',\n",
       "    'url': 'https://ec.europa.eu/eurostat/cache/metadata/Annexes/isoc_i_simsih2_se_an_7.pdf',\n",
       "    'title': 'Use of IT by individuals 2024',\n",
       "    'content': None,\n",
       "    'excerpt': 'companies or private persons and second-hand goods. Several answers can be marked. Clothes (including sport clothing), shoes or accessories (e.g. bags, jewellery) Sports goods (excluding sport clothin',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:51.216264'},\n",
       "   {'id': 'spec_b19a87c4',\n",
       "    'url': 'https://energy-efficient-products.ec.europa.eu/product-list/air-conditioners-and-comfort-fans_en',\n",
       "    'title': 'Air Conditioners and Comfort Fans - European Commission',\n",
       "    'content': None,\n",
       "    'excerpt': 'en\\n\\nSelect your language\\n\\nEU official languages\\n\\n bgбългарски\\n esespañol\\n csčeština\\n dadansk\\n deDeutsch\\n eteesti\\n elελληνικά\\n enEnglish\\n frfrançais\\n gaGaeilge\\n hrhrvatski\\n ititaliano\\n lvlatviešu\\n ltli',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'EU',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:51.216264'},\n",
       "   {'id': 'spec_ffc2f2a3',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161155.pdf',\n",
       "    'title': '001_Origin Coxa Vara Hip 510k Application',\n",
       "    'content': None,\n",
       "    'excerpt': 'DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Signature Orthopaed',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:52.450816'},\n",
       "   {'id': 'spec_30a465fd',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192189.pdf',\n",
       "    'title': 'December 18, 2019 Zimmer, Inc. Neha Sreenath Senior ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'U.S. Food & Drug Administration 10903 New Hampshire Avenue D o c I D # 0 4 0 1 7 . 0 4 . 1 2 Silver Spring, MD 20993 www.fda.gov December 18, 2019 Zimmer, Inc. ℅ Neha Sreenath Senior Specialist, Regul',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:52.450816'},\n",
       "   {'id': 'spec_925eaed6',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf24/K243466.pdf',\n",
       "    'title': 'January 6, 2025 United Orthopedic Corporation Lois Ho Regulatory ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'subject device is an extension line of 510(K) cleared device Conformity stem, cementless (K183312, K242249), which introduces four new variations: (1) Conformity stem, #0; (2) Conformity stem, collare',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:52.450816'},\n",
       "   {'id': 'spec_388f9961',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232371.pdf',\n",
       "    'title': 'October 19, 2023 implantcast, GmbH Juliane Hoppner ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Device Description: The purpose of this Traditional 510(k) is to introduce into interstate commerce in the United States the Actinia® hip stems. The Actinia® hip stems are femoral stems for total or h',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:52.450816'},\n",
       "   {'id': 'spec_db8511ba',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233476.pdf',\n",
       "    'title': 'February 8, 2024 Orchard Medical Development Justin ...',\n",
       "    'content': None,\n",
       "    'excerpt': '0, 1, 2, 3, 4, 5, 6, 6.5, 7, 7.5, 8, 8.5, 9 Collar Collared, Collarless Collared, Collarless Page 3 of 4 Device Characteristic Subject Device Orchard Medical Z1 Hip Stem Primary Predicate Device Zimme',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:52.451559'},\n",
       "   {'id': 'spec_1730e5bd',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161155.pdf',\n",
       "    'title': '001_Origin Coxa Vara Hip 510k Application',\n",
       "    'content': None,\n",
       "    'excerpt': 'Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:53.618047'},\n",
       "   {'id': 'spec_1b001bc3',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf24/K243466.pdf',\n",
       "    'title': 'January 6, 2025 United Orthopedic Corporation Lois Ho Regulatory ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Dr',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:53.618047'},\n",
       "   {'id': 'spec_e1cbca7b',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233476.pdf',\n",
       "    'title': 'February 8, 2024 Orchard Medical Development Justin ...',\n",
       "    'content': None,\n",
       "    'excerpt': '0 8 Silver Spring, MD 20993 www.fda.gov February 8, 2024 Orchard Medical Development ℅ Justin Gracyalny Regulatory Affairs Manager Secure BioMed Evalutations 7828 Hickory Flat Highway, Suite 120 Woods',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:53.618047'},\n",
       "   {'id': 'spec_1f3a9b59',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232371.pdf',\n",
       "    'title': 'October 19, 2023 implantcast, GmbH Juliane Hoppner ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'October 19, 2023 implantcast, GmbH ℅ Juliane Hoppner Regulatory Affairs Manager Implantcast GmbH Luneburger Schanze 26 Buxtehude, Germany Re: K232371 Trade/Device Name: Actinia® hip stems Regulation N',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:53.618047'},\n",
       "   {'id': 'spec_8b57dd00',\n",
       "    'url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240528.pdf',\n",
       "    'title': 'November 15, 2024 b-ONE Ortho, Corp. Allison Gecik Director ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Allison Gecik Director, US Quality & Regulatory 3 Wing Drive Suite 259 Cedar Knolls, New Jersey 07927 Re: K240528 Trade/Device Name: b-ONE® Total Hip System Regulation Number: 21 CFR 888.3353 Regulati',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'regulatory',\n",
       "    'publisher': 'FDA',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.95,\n",
       "    'reliability_reasons': ['규제 기관 공식 문서', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:53.618047'},\n",
       "   {'id': 'spec_14b7fb1b',\n",
       "    'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3680762/',\n",
       "    'title': 'VARA attenuates hyperoxia-induced impaired alveolar ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'by ML James · 2013 · Cited by 59 — The present study is the first to determine the functional benefits of increased lung retinoids using the VARA combination on alveolar development and lung',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:54.717800'},\n",
       "   {'id': 'spec_20040647',\n",
       "    'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC3843131/',\n",
       "    'title': 'The Components of VARA, a Nutrient-Metabolite ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'by AC Ross · 2006 · Cited by 37 — In a dose-dilution study, VARA was 4 times as effective as the standard dose of VA (VARA-25% did not differ from VA-100%). The synergistic effect of VARA was',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:54.717800'},\n",
       "   {'id': 'spec_6cb7b344',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT04683003',\n",
       "    'title': 'NCT04683003 | A Study of TAK-755 in Participants With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'La Coruña Locations\\n\\nA Coruña, La Coruña, Spain, 15006\\n\\nRecruiting\\n\\nComplejo Hospitalario Universitario A Coruña\\n\\nContact : \\n\\nSite contact\\n\\n+34 981 17 66 68ma.fernanda.lopez.fernandez@sergas.es\\n\\nPrinc',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:54.717800'},\n",
       "   {'id': 'spec_152c32e9',\n",
       "    'url': 'https://www.clinicaltrials.gov/study/NCT05714969',\n",
       "    'title': 'NCT05714969 | A Study of TAK-755 (rADAMTS13) With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Clinical study A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: interventional studies (als',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:54.717800'},\n",
       "   {'id': 'spec_8be45b9f',\n",
       "    'url': 'https://www.clinicaltrials.gov/study/NCT02175212',\n",
       "    'title': 'Clinical Trials of Adjuvant Androgen Deprivation in ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'The present study is a phase III randomized and multicentric trial evaluating the potential additional impact effect of two years adjuvant androgen',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:54.717800'},\n",
       "   {'id': 'spec_4c062cba',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT05714969',\n",
       "    'title': 'NCT05714969 | A Study of TAK-755 (rADAMTS13) With ...',\n",
       "    'content': None,\n",
       "    'excerpt': '+34946006000miriam.varapampliega@osakidetza.eus%20With%20Little%20to%20No%20Plasma%20Exchange%20(PEX)%20Treatment%20in%20Adults%20With%20Immune-mediated%20Thrombotic%20Thrombocytopenic%20Purpura%20(iT',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:55.885439'},\n",
       "   {'id': 'spec_86b35654',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT04683003',\n",
       "    'title': 'NCT04683003 | A Study of TAK-755 in Participants With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'ClinicalTrials.gov is a website and online database of clinical research studies and information about their results. The National Library of Medicine (NLM) maintains the website. The study sponsor or',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:55.885439'},\n",
       "   {'id': 'spec_c58d5da3',\n",
       "    'url': 'https://clinicaltrials.gov/search?cond=(CAMPTODACTYLY-ARTHROPATHY-COXA%20VARA-PERICARDITIS%20SYNDROME)%20OR%20(igg4)&checkSpell=',\n",
       "    'title': 'Search for: (CAMPTODACTYLY-ARTHROPATHY-COXA VARA ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'A phase of research used to describe exploratory trials conducted before traditional phase 1 trials to investigate how or whether a drug affects the body. They',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:55.885439'},\n",
       "   {'id': 'spec_0bfeedd1',\n",
       "    'url': 'https://clinicaltrials.gov/search?cond=COXA%20VARA',\n",
       "    'title': 'Clinical Trials',\n",
       "    'content': None,\n",
       "    'excerpt': 'No information is available for this page.',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:55.885439'},\n",
       "   {'id': 'spec_50b9b93a',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT06680830',\n",
       "    'title': 'NCT06680830 | A Phase 2 Study of NEU-411 in ...',\n",
       "    'content': None,\n",
       "    'excerpt': \"The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's\",\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:55.885439'},\n",
       "   {'id': 'spec_49e0e4a6',\n",
       "    'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5497696/',\n",
       "    'title': 'MERGING VETERANS AFFAIRS RHEUMATOID ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'by GW Cannon · 2011 · Cited by 108 — Clinical outcomes during methotrexate therapy. Mean (± SD) disease activity values during VARA follow-up are summarized in Table 3. In these unadjusted analyses',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:56.953001'},\n",
       "   {'id': 'spec_a4686843',\n",
       "    'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC6363303/',\n",
       "    'title': 'Insights and Implications of the VA Rheumatoid Arthritis ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'by TR Mikuls · 2015 · Cited by 36 — The VARA has served as a valuable resource for a wide scope of clinical and clinical-translational research, ranging from studies of disease outcomes and their',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:56.953603'},\n",
       "   {'id': 'spec_10c56031',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/40523921/',\n",
       "    'title': 'Exploratory digital outcome measures of motor sign ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease.Vis',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:56.953603'},\n",
       "   {'id': 'spec_b35ec527',\n",
       "    'url': 'https://www.clinicaltrials.gov/study/NCT05714969',\n",
       "    'title': 'NCT05714969 | A Study of TAK-755 (rADAMTS13) With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Study results A study record that includes the summary results posted in the ClinicalTrials.gov results database. Summary results information includes participant flow, baseline characteristics, outco',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:56.953603'},\n",
       "   {'id': 'spec_d2a32074',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT06680830',\n",
       "    'title': 'NCT06680830 | A Phase 2 Study of NEU-411 in ...',\n",
       "    'content': None,\n",
       "    'excerpt': \"The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's\",\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:56.953603'},\n",
       "   {'id': 'spec_c65b9b4c',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/20522533/',\n",
       "    'title': 'Improvement in growth after 1 year of growth hormone ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'The study design included randomized, parallel groups in an open, multicenter trial comparing GH (0.33 mg/kg per wk) with nontreatment with GH during 12 months. Sixteen infants who had growth retardat',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:58.171491'},\n",
       "   {'id': 'spec_7353edb9',\n",
       "    'url': 'https://www.clinicaltrials.gov/study/NCT02175212',\n",
       "    'title': 'Clinical Trials of Adjuvant Androgen Deprivation in ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'The present study is a phase III randomized and multicentric trial evaluating the potential additional impact effect of two years adjuvant androgen',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:58.171491'},\n",
       "   {'id': 'spec_969a9689',\n",
       "    'url': 'https://clinicaltrials.gov/study/NCT04683003',\n",
       "    'title': 'NCT04683003 | A Study of TAK-755 in Participants With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'La Coruña Locations\\n\\nA Coruña, La Coruña, Spain, 15006\\n\\nRecruiting\\n\\nComplejo Hospitalario Universitario A Coruña\\n\\nContact : \\n\\nSite contact\\n\\n+34 981 17 66 68ma.fernanda.lopez.fernandez@sergas.es\\n\\nPrinc',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:58.171491'},\n",
       "   {'id': 'spec_dc769e87',\n",
       "    'url': 'https://www.clinicaltrials.gov/study/NCT05714969',\n",
       "    'title': 'NCT05714969 | A Study of TAK-755 (rADAMTS13) With ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'Study results A study record that includes the summary results posted in the ClinicalTrials.gov results database. Summary results information includes participant flow, baseline characteristics, outco',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'ClinicalTrials.gov',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:58.171491'},\n",
       "   {'id': 'spec_52407cd7',\n",
       "    'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC5497696/',\n",
       "    'title': 'MERGING VETERANS AFFAIRS RHEUMATOID ...',\n",
       "    'content': None,\n",
       "    'excerpt': 'by GW Cannon · 2011 · Cited by 108 — High MTX adherence was associated with improved clinical outcomes in RA patients treated with MTX. Adjustment for potential confounders did not alter the',\n",
       "    'source_type': 'primary',\n",
       "    'source_category': 'clinical_trial',\n",
       "    'publisher': 'WHO',\n",
       "    'author': None,\n",
       "    'date': None,\n",
       "    'age_days': 0,\n",
       "    'is_recent': False,\n",
       "    'reliability': 'high',\n",
       "    'reliability_score': 0.92,\n",
       "    'reliability_reasons': ['임상시험 등록 데이터', '1차 출처'],\n",
       "    'evidence_tier': 'tier1',\n",
       "    'is_verified': False,\n",
       "    'verified_by': [],\n",
       "    'collected_by': 'specialized_collection',\n",
       "    'collected_at': '2025-10-22T20:04:58.171491'}],\n",
       "  'count': 90,\n",
       "  'sources': ['academic', 'clinical_trial', 'regulatory'],\n",
       "  'sources_breakdown': {'academic': 40,\n",
       "   'regulatory': 30,\n",
       "   'clinical_trial': 20},\n",
       "  'primary_sources_count': 90,\n",
       "  'secondary_sources_count': 0,\n",
       "  'newest_date': None,\n",
       "  'oldest_date': None,\n",
       "  'recent_documents_count': 0,\n",
       "  'high_reliability_count': 90,\n",
       "  'medium_reliability_count': 0,\n",
       "  'low_reliability_count': 0,\n",
       "  'average_reliability': 0.92,\n",
       "  'error': None},\n",
       " 'merged_documents': [],\n",
       " 'quality_score': {'diversity': 0,\n",
       "  'primary_ratio': 0,\n",
       "  'recency': 0,\n",
       "  'total': 0,\n",
       "  'breakdown': {'primary_sources': [],\n",
       "   'secondary_sources': [],\n",
       "   'sources_by_category': {},\n",
       "   'topics_covered': [],\n",
       "   'missing_topics': [],\n",
       "   'recent_documents': [],\n",
       "   'outdated_documents': [],\n",
       "   'recency_threshold_days': 180,\n",
       "   'high_reliability_docs': [],\n",
       "   'low_reliability_docs': [],\n",
       "   'verified_documents': []},\n",
       "  'overall_reliability': 0.0,\n",
       "  'confidence': 0.0},\n",
       " 'is_data_sufficient': False,\n",
       " 'retry_collection': 0,\n",
       " 'collection_focus': [],\n",
       " 'analysis_result': {'summary': '',\n",
       "  'key_facts': [],\n",
       "  'risks': [],\n",
       "  'business_model': '',\n",
       "  'target_users': [],\n",
       "  'technology_stack': [],\n",
       "  'sources_used': [],\n",
       "  'primary_sources_used': [],\n",
       "  'total_sources_count': 0},\n",
       " 'analysis_score': {'evidence_strength': 0,\n",
       "  'cross_validation': 0,\n",
       "  'total': 0,\n",
       "  'confidence': 0.0,\n",
       "  'confidence_factors': {}},\n",
       " 'is_analysis_sufficient': False,\n",
       " 'retry_analysis': 0,\n",
       " 'ethics_evaluation': {'transparency': {'score': 0,\n",
       "   'level': 0,\n",
       "   'confidence': 0.0,\n",
       "   'evidence': [],\n",
       "   'issues': [],\n",
       "   'strengths': [],\n",
       "   'evidence_count': 0,\n",
       "   'tier1_evidence_count': 0,\n",
       "   'direct_evidence_count': 0,\n",
       "   'information_availability': 'none',\n",
       "   'limitations': []},\n",
       "  'human_oversight': {'score': 0,\n",
       "   'level': 0,\n",
       "   'confidence': 0.0,\n",
       "   'evidence': [],\n",
       "   'issues': [],\n",
       "   'strengths': [],\n",
       "   'evidence_count': 0,\n",
       "   'tier1_evidence_count': 0,\n",
       "   'direct_evidence_count': 0,\n",
       "   'information_availability': 'none',\n",
       "   'limitations': []},\n",
       "  'data_governance': {'score': 0,\n",
       "   'level': 0,\n",
       "   'confidence': 0.0,\n",
       "   'evidence': [],\n",
       "   'issues': [],\n",
       "   'strengths': [],\n",
       "   'evidence_count': 0,\n",
       "   'tier1_evidence_count': 0,\n",
       "   'direct_evidence_count': 0,\n",
       "   'information_availability': 'none',\n",
       "   'limitations': []},\n",
       "  'accuracy_validation': {'score': 0,\n",
       "   'level': 0,\n",
       "   'confidence': 0.0,\n",
       "   'evidence': [],\n",
       "   'issues': [],\n",
       "   'strengths': [],\n",
       "   'evidence_count': 0,\n",
       "   'tier1_evidence_count': 0,\n",
       "   'direct_evidence_count': 0,\n",
       "   'information_availability': 'none',\n",
       "   'limitations': []},\n",
       "  'accountability': {'score': 0,\n",
       "   'level': 0,\n",
       "   'confidence': 0.0,\n",
       "   'evidence': [],\n",
       "   'issues': [],\n",
       "   'strengths': [],\n",
       "   'evidence_count': 0,\n",
       "   'tier1_evidence_count': 0,\n",
       "   'direct_evidence_count': 0,\n",
       "   'information_availability': 'none',\n",
       "   'limitations': []},\n",
       "  'all_sources_used': [],\n",
       "  'total_evidence_count': 0},\n",
       " 'ethics_score': {'transparency': 0,\n",
       "  'human_oversight': 0,\n",
       "  'data_governance': 0,\n",
       "  'accuracy_validation': 0,\n",
       "  'accountability': 0,\n",
       "  'total': 0,\n",
       "  'grade': 'N/A',\n",
       "  'overall_confidence': 0.0,\n",
       "  'confidence_by_category': {},\n",
       "  'average_evidence_quality': 0.0},\n",
       " 'critical_issues': [],\n",
       " 'social_analysis': {'media_sentiment': {'score': 0.0,\n",
       "   'positive_count': 0,\n",
       "   'negative_count': 0,\n",
       "   'neutral_count': 0,\n",
       "   'key_articles': [],\n",
       "   'analyzed_articles': [],\n",
       "   'high_impact_articles': [],\n",
       "   'sentiment_confidence': 0.0},\n",
       "  'expert_opinions': [],\n",
       "  'controversies': [],\n",
       "  'regulatory_actions': [],\n",
       "  'all_sources_analyzed': []},\n",
       " 'social_score': {'media_reputation': 0,\n",
       "  'expert_trust': 0,\n",
       "  'controversy_level': 0,\n",
       "  'total': 0,\n",
       "  'analysis_confidence': 0.0,\n",
       "  'data_recency': 'mixed'},\n",
       " 'final_scores': {'data_quality': 0,\n",
       "  'analysis_reliability': 0,\n",
       "  'ethics': 0,\n",
       "  'social_trust': 0,\n",
       "  'total': 0,\n",
       "  'grade': 'N/A',\n",
       "  'risk_level': 'UNKNOWN',\n",
       "  'overall_confidence': 0.0,\n",
       "  'confidence_breakdown': {},\n",
       "  'total_sources_used': 0,\n",
       "  'primary_sources_ratio': 0.0,\n",
       "  'average_source_reliability': 0.0,\n",
       "  'oldest_source_age_days': 0,\n",
       "  'newest_source_age_days': 0},\n",
       " 'report_content': {'executive_summary': '',\n",
       "  'detailed_findings': {},\n",
       "  'comparison_benchmark': None,\n",
       "  'recommendations': [],\n",
       "  'limitations': [],\n",
       "  'sources_section': {'all_document_ids': [],\n",
       "   'documents_by_stage': {},\n",
       "   'citations': []},\n",
       "  'reliability_statement': '',\n",
       "  'confidence_caveats': []},\n",
       " 'report_path': None,\n",
       " 'source_summary': {'all_document_ids': [],\n",
       "  'documents_by_stage': {'collection': [],\n",
       "   'analysis': [],\n",
       "   'ethics': [],\n",
       "   'social': []},\n",
       "  'citations': []},\n",
       " 'warnings': [],\n",
       " 'limitations': [],\n",
       " 'errors': [],\n",
       " 'execution_log': []}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "56502073",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: chromadb in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (0.4.24)\n",
      "Collecting chromadb\n",
      "  Downloading chromadb-1.2.1-cp39-abi3-win_amd64.whl.metadata (7.4 kB)\n",
      "Requirement already satisfied: sentence-transformers in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (5.1.1)\n",
      "Collecting FlagEmbedding\n",
      "  Downloading FlagEmbedding-1.3.5.tar.gz (163 kB)\n",
      "  Installing build dependencies: started\n",
      "  Installing build dependencies: finished with status 'done'\n",
      "  Getting requirements to build wheel: started\n",
      "  Getting requirements to build wheel: finished with status 'done'\n",
      "  Preparing metadata (pyproject.toml): started\n",
      "  Preparing metadata (pyproject.toml): finished with status 'done'\n",
      "Requirement already satisfied: pypdf in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (4.3.1)\n",
      "Collecting pypdf\n",
      "  Downloading pypdf-6.1.2-py3-none-any.whl.metadata (7.1 kB)\n",
      "Requirement already satisfied: tqdm in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (4.67.1)\n",
      "Requirement already satisfied: build>=1.0.3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.3.0)\n",
      "Requirement already satisfied: pydantic>=1.9 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (2.12.2)\n",
      "Collecting pybase64>=1.4.1 (from chromadb)\n",
      "  Using cached pybase64-1.4.2-cp311-cp311-win_amd64.whl.metadata (9.0 kB)\n",
      "Requirement already satisfied: uvicorn>=0.18.3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from uvicorn[standard]>=0.18.3->chromadb) (0.37.0)\n",
      "Requirement already satisfied: numpy>=1.22.5 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (2.3.4)\n",
      "Collecting posthog<6.0.0,>=2.4.0 (from chromadb)\n",
      "  Using cached posthog-5.4.0-py3-none-any.whl.metadata (5.7 kB)\n",
      "Requirement already satisfied: typing-extensions>=4.5.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (4.15.0)\n",
      "Requirement already satisfied: onnxruntime>=1.14.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.23.1)\n",
      "Requirement already satisfied: opentelemetry-api>=1.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.38.0)\n",
      "Requirement already satisfied: opentelemetry-exporter-otlp-proto-grpc>=1.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.15.0)\n",
      "Requirement already satisfied: opentelemetry-sdk>=1.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.38.0)\n",
      "Requirement already satisfied: tokenizers>=0.13.2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (0.19.1)\n",
      "Requirement already satisfied: pypika>=0.48.9 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (0.48.9)\n",
      "Requirement already satisfied: overrides>=7.3.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (7.7.0)\n",
      "Requirement already satisfied: importlib-resources in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (6.5.2)\n",
      "Requirement already satisfied: grpcio>=1.58.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (1.75.1)\n",
      "Requirement already satisfied: bcrypt>=4.0.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (5.0.0)\n",
      "Requirement already satisfied: typer>=0.9.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (0.19.2)\n",
      "Requirement already satisfied: kubernetes>=28.1.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (34.1.0)\n",
      "Requirement already satisfied: tenacity>=8.2.3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (9.1.2)\n",
      "Requirement already satisfied: pyyaml>=6.0.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (6.0.3)\n",
      "Requirement already satisfied: mmh3>=4.0.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (4.1.0)\n",
      "Requirement already satisfied: orjson>=3.9.12 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (3.11.3)\n",
      "Requirement already satisfied: httpx>=0.27.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (0.28.1)\n",
      "Requirement already satisfied: rich>=10.11.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (14.2.0)\n",
      "Requirement already satisfied: jsonschema>=4.19.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from chromadb) (4.25.1)\n",
      "Requirement already satisfied: requests<3.0,>=2.7 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from posthog<6.0.0,>=2.4.0->chromadb) (2.32.5)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from posthog<6.0.0,>=2.4.0->chromadb) (1.17.0)\n",
      "Requirement already satisfied: python-dateutil>=2.2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from posthog<6.0.0,>=2.4.0->chromadb) (2.9.0.post0)\n",
      "Requirement already satisfied: backoff>=1.10.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from posthog<6.0.0,>=2.4.0->chromadb) (2.2.1)\n",
      "Requirement already satisfied: distro>=1.5.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from posthog<6.0.0,>=2.4.0->chromadb) (1.9.0)\n",
      "Requirement already satisfied: charset_normalizer<4,>=2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from requests<3.0,>=2.7->posthog<6.0.0,>=2.4.0->chromadb) (3.4.4)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from requests<3.0,>=2.7->posthog<6.0.0,>=2.4.0->chromadb) (3.11)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from requests<3.0,>=2.7->posthog<6.0.0,>=2.4.0->chromadb) (2.3.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from requests<3.0,>=2.7->posthog<6.0.0,>=2.4.0->chromadb) (2025.10.5)\n",
      "Requirement already satisfied: transformers<5.0.0,>=4.41.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (4.44.2)\n",
      "Requirement already satisfied: torch>=1.11.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (2.2.2)\n",
      "Requirement already satisfied: scikit-learn in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (1.7.2)\n",
      "Requirement already satisfied: scipy in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (1.16.2)\n",
      "Requirement already satisfied: huggingface-hub>=0.20.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (0.25.2)\n",
      "Requirement already satisfied: Pillow in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sentence-transformers) (10.4.0)\n",
      "Requirement already satisfied: filelock in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (3.20.0)\n",
      "Requirement already satisfied: packaging>=20.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (25.0)\n",
      "Requirement already satisfied: regex!=2019.12.17 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (2025.9.18)\n",
      "Requirement already satisfied: safetensors>=0.4.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (0.6.2)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (2025.9.0)\n",
      "Requirement already satisfied: datasets>=2.19.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from FlagEmbedding) (4.2.0)\n",
      "Collecting accelerate>=0.20.1 (from FlagEmbedding)\n",
      "  Downloading accelerate-1.11.0-py3-none-any.whl.metadata (19 kB)\n",
      "Collecting peft (from FlagEmbedding)\n",
      "  Downloading peft-0.17.1-py3-none-any.whl.metadata (14 kB)\n",
      "Collecting ir-datasets (from FlagEmbedding)\n",
      "  Downloading ir_datasets-0.5.11-py3-none-any.whl.metadata (12 kB)\n",
      "Collecting sentencepiece (from FlagEmbedding)\n",
      "  Downloading sentencepiece-0.2.1-cp311-cp311-win_amd64.whl.metadata (10 kB)\n",
      "Requirement already satisfied: protobuf in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from FlagEmbedding) (3.20.3)\n",
      "Requirement already satisfied: colorama in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from tqdm) (0.4.6)\n",
      "Requirement already satisfied: psutil in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from accelerate>=0.20.1->FlagEmbedding) (7.1.0)\n",
      "Requirement already satisfied: pyproject_hooks in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from build>=1.0.3->chromadb) (1.2.0)\n",
      "Requirement already satisfied: pyarrow>=21.0.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from datasets>=2.19.0->FlagEmbedding) (21.0.0)\n",
      "Requirement already satisfied: dill<0.4.1,>=0.3.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from datasets>=2.19.0->FlagEmbedding) (0.4.0)\n",
      "Requirement already satisfied: pandas in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from datasets>=2.19.0->FlagEmbedding) (2.3.3)\n",
      "Requirement already satisfied: xxhash in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from datasets>=2.19.0->FlagEmbedding) (3.6.0)\n",
      "Requirement already satisfied: multiprocess<0.70.17 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from datasets>=2.19.0->FlagEmbedding) (0.70.16)\n",
      "Requirement already satisfied: aiohttp!=4.0.0a0,!=4.0.0a1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (3.13.0)\n",
      "Requirement already satisfied: anyio in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from httpx>=0.27.0->chromadb) (4.11.0)\n",
      "Requirement already satisfied: httpcore==1.* in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from httpx>=0.27.0->chromadb) (1.0.9)\n",
      "Requirement already satisfied: h11>=0.16 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from httpcore==1.*->httpx>=0.27.0->chromadb) (0.16.0)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (2.6.1)\n",
      "Requirement already satisfied: aiosignal>=1.4.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (1.4.0)\n",
      "Requirement already satisfied: attrs>=17.3.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (25.4.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (1.8.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (6.7.0)\n",
      "Requirement already satisfied: propcache>=0.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (0.4.1)\n",
      "Requirement already satisfied: yarl<2.0,>=1.17.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]<=2025.9.0,>=2023.1.0->datasets>=2.19.0->FlagEmbedding) (1.22.0)\n",
      "Requirement already satisfied: jsonschema-specifications>=2023.03.6 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from jsonschema>=4.19.0->chromadb) (2025.9.1)\n",
      "Requirement already satisfied: referencing>=0.28.4 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from jsonschema>=4.19.0->chromadb) (0.37.0)\n",
      "Requirement already satisfied: rpds-py>=0.7.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from jsonschema>=4.19.0->chromadb) (0.27.1)\n",
      "Requirement already satisfied: google-auth>=1.0.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from kubernetes>=28.1.0->chromadb) (2.41.1)\n",
      "Requirement already satisfied: websocket-client!=0.40.0,!=0.41.*,!=0.42.*,>=0.32.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from kubernetes>=28.1.0->chromadb) (1.9.0)\n",
      "Requirement already satisfied: requests-oauthlib in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from kubernetes>=28.1.0->chromadb) (2.0.0)\n",
      "Requirement already satisfied: durationpy>=0.7 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from kubernetes>=28.1.0->chromadb) (0.10)\n",
      "Requirement already satisfied: cachetools<7.0,>=2.0.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (6.2.1)\n",
      "Requirement already satisfied: pyasn1-modules>=0.2.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (0.4.2)\n",
      "Requirement already satisfied: rsa<5,>=3.1.4 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (4.9.1)\n",
      "Requirement already satisfied: pyasn1>=0.1.3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from rsa<5,>=3.1.4->google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (0.6.1)\n",
      "Requirement already satisfied: coloredlogs in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from onnxruntime>=1.14.1->chromadb) (15.0.1)\n",
      "Requirement already satisfied: flatbuffers in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from onnxruntime>=1.14.1->chromadb) (25.9.23)\n",
      "Requirement already satisfied: sympy in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from onnxruntime>=1.14.1->chromadb) (1.14.0)\n",
      "Requirement already satisfied: importlib-metadata<8.8.0,>=6.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from opentelemetry-api>=1.2.0->chromadb) (8.7.0)\n",
      "Requirement already satisfied: zipp>=3.20 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from importlib-metadata<8.8.0,>=6.0->opentelemetry-api>=1.2.0->chromadb) (3.23.0)\n",
      "Requirement already satisfied: googleapis-common-protos~=1.52 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb) (1.70.0)\n",
      "Requirement already satisfied: opentelemetry-proto==1.15.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb) (1.15.0)\n",
      "Requirement already satisfied: opentelemetry-semantic-conventions==0.59b0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from opentelemetry-sdk>=1.2.0->chromadb) (0.59b0)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from pydantic>=1.9->chromadb) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.41.4 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from pydantic>=1.9->chromadb) (2.41.4)\n",
      "Requirement already satisfied: typing-inspection>=0.4.2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from pydantic>=1.9->chromadb) (0.4.2)\n",
      "Requirement already satisfied: markdown-it-py>=2.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from rich>=10.11.0->chromadb) (4.0.0)\n",
      "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from rich>=10.11.0->chromadb) (2.19.2)\n",
      "Requirement already satisfied: mdurl~=0.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->chromadb) (0.1.2)\n",
      "Requirement already satisfied: networkx in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from torch>=1.11.0->sentence-transformers) (3.5)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from torch>=1.11.0->sentence-transformers) (3.1.6)\n",
      "Requirement already satisfied: click>=8.0.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from typer>=0.9.0->chromadb) (8.3.0)\n",
      "Requirement already satisfied: shellingham>=1.3.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from typer>=0.9.0->chromadb) (1.5.4)\n",
      "Requirement already satisfied: httptools>=0.6.3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from uvicorn[standard]>=0.18.3->chromadb) (0.7.1)\n",
      "Requirement already satisfied: python-dotenv>=0.13 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from uvicorn[standard]>=0.18.3->chromadb) (1.1.1)\n",
      "Requirement already satisfied: watchfiles>=0.13 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from uvicorn[standard]>=0.18.3->chromadb) (1.1.1)\n",
      "Requirement already satisfied: websockets>=10.4 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from uvicorn[standard]>=0.18.3->chromadb) (15.0.1)\n",
      "Requirement already satisfied: sniffio>=1.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from anyio->httpx>=0.27.0->chromadb) (1.3.1)\n",
      "Requirement already satisfied: humanfriendly>=9.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from coloredlogs->onnxruntime>=1.14.1->chromadb) (10.0)\n",
      "Requirement already satisfied: pyreadline3 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from humanfriendly>=9.1->coloredlogs->onnxruntime>=1.14.1->chromadb) (3.5.4)\n",
      "Requirement already satisfied: beautifulsoup4>=4.4.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from ir-datasets->FlagEmbedding) (4.14.2)\n",
      "Collecting inscriptis>=2.2.0 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading inscriptis-2.6.0-py3-none-any.whl.metadata (25 kB)\n",
      "Requirement already satisfied: lxml>=4.5.2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from ir-datasets->FlagEmbedding) (5.4.0)\n",
      "Collecting trec-car-tools>=2.5.4 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading trec_car_tools-2.6-py3-none-any.whl.metadata (640 bytes)\n",
      "Requirement already satisfied: lz4>=3.1.10 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from ir-datasets->FlagEmbedding) (4.4.4)\n",
      "Collecting warc3-wet>=0.2.3 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading warc3_wet-0.2.5-py3-none-any.whl.metadata (2.2 kB)\n",
      "Collecting warc3-wet-clueweb09>=0.2.5 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading warc3-wet-clueweb09-0.2.5.tar.gz (17 kB)\n",
      "  Installing build dependencies: started\n",
      "  Installing build dependencies: finished with status 'done'\n",
      "  Getting requirements to build wheel: started\n",
      "  Getting requirements to build wheel: finished with status 'done'\n",
      "  Preparing metadata (pyproject.toml): started\n",
      "  Preparing metadata (pyproject.toml): finished with status 'done'\n",
      "Collecting zlib-state>=0.1.3 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading zlib_state-0.1.10-cp311-cp311-win_amd64.whl.metadata (3.6 kB)\n",
      "Collecting ijson>=3.1.3 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading ijson-3.4.0.post0-cp311-cp311-win_amd64.whl.metadata (24 kB)\n",
      "Collecting unlzw3>=0.2.1 (from ir-datasets->FlagEmbedding)\n",
      "  Downloading unlzw3-0.2.3-py3-none-any.whl.metadata (2.3 kB)\n",
      "Requirement already satisfied: soupsieve>1.2 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from beautifulsoup4>=4.4.1->ir-datasets->FlagEmbedding) (2.8)\n",
      "Collecting cbor>=1.0.0 (from trec-car-tools>=2.5.4->ir-datasets->FlagEmbedding)\n",
      "  Downloading cbor-1.0.0.tar.gz (20 kB)\n",
      "  Installing build dependencies: started\n",
      "  Installing build dependencies: finished with status 'done'\n",
      "  Getting requirements to build wheel: started\n",
      "  Getting requirements to build wheel: finished with status 'done'\n",
      "  Preparing metadata (pyproject.toml): started\n",
      "  Preparing metadata (pyproject.toml): finished with status 'done'\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from jinja2->torch>=1.11.0->sentence-transformers) (3.0.3)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from pandas->datasets>=2.19.0->FlagEmbedding) (2025.2)\n",
      "Requirement already satisfied: tzdata>=2022.7 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from pandas->datasets>=2.19.0->FlagEmbedding) (2025.2)\n",
      "Requirement already satisfied: oauthlib>=3.0.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from requests-oauthlib->kubernetes>=28.1.0->chromadb) (3.3.1)\n",
      "Requirement already satisfied: joblib>=1.2.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from scikit-learn->sentence-transformers) (1.5.2)\n",
      "Requirement already satisfied: threadpoolctl>=3.1.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from scikit-learn->sentence-transformers) (3.6.0)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\skax\\appdata\\local\\pypoetry\\cache\\virtualenvs\\langchain-kr-607hawwd-py3.11\\lib\\site-packages (from sympy->onnxruntime>=1.14.1->chromadb) (1.3.0)\n",
      "Downloading chromadb-1.2.1-cp39-abi3-win_amd64.whl (20.7 MB)\n",
      "   ---------------------------------------- 0.0/20.7 MB ? eta -:--:--\n",
      "   --------------------------- ------------ 14.2/20.7 MB 68.1 MB/s eta 0:00:01\n",
      "   ---------------------------------------  20.4/20.7 MB 68.0 MB/s eta 0:00:01\n",
      "   ---------------------------------------  20.4/20.7 MB 68.0 MB/s eta 0:00:01\n",
      "   ---------------------------------------  20.4/20.7 MB 68.0 MB/s eta 0:00:01\n",
      "   ---------------------------------------- 20.7/20.7 MB 23.3 MB/s  0:00:00\n",
      "Using cached posthog-5.4.0-py3-none-any.whl (105 kB)\n",
      "Downloading pypdf-6.1.2-py3-none-any.whl (323 kB)\n",
      "Downloading accelerate-1.11.0-py3-none-any.whl (375 kB)\n",
      "Using cached pybase64-1.4.2-cp311-cp311-win_amd64.whl (35 kB)\n",
      "Downloading ir_datasets-0.5.11-py3-none-any.whl (866 kB)\n",
      "   ---------------------------------------- 0.0/866.1 kB ? eta -:--:--\n",
      "   ---------------------------------------- 866.1/866.1 kB 18.9 MB/s  0:00:00\n",
      "Downloading ijson-3.4.0.post0-cp311-cp311-win_amd64.whl (54 kB)\n",
      "Downloading inscriptis-2.6.0-py3-none-any.whl (45 kB)\n",
      "Downloading trec_car_tools-2.6-py3-none-any.whl (8.4 kB)\n",
      "Downloading unlzw3-0.2.3-py3-none-any.whl (6.7 kB)\n",
      "Downloading warc3_wet-0.2.5-py3-none-any.whl (18 kB)\n",
      "Downloading zlib_state-0.1.10-cp311-cp311-win_amd64.whl (12 kB)\n",
      "Downloading peft-0.17.1-py3-none-any.whl (504 kB)\n",
      "Downloading sentencepiece-0.2.1-cp311-cp311-win_amd64.whl (1.1 MB)\n",
      "   ---------------------------------------- 0.0/1.1 MB ? eta -:--:--\n",
      "   ---------------------------------------- 1.1/1.1 MB 16.9 MB/s  0:00:00\n",
      "Building wheels for collected packages: FlagEmbedding, cbor, warc3-wet-clueweb09\n",
      "  Building wheel for FlagEmbedding (pyproject.toml): started\n",
      "  Building wheel for FlagEmbedding (pyproject.toml): finished with status 'done'\n",
      "  Created wheel for FlagEmbedding: filename=flagembedding-1.3.5-py3-none-any.whl size=233858 sha256=f0d1e2006c976ac5dcda32fa00cfa0a657a4aea0e0ddaa0652c73d4e1cff7376\n",
      "  Stored in directory: c:\\users\\skax\\appdata\\local\\pip\\cache\\wheels\\fc\\1c\\66\\c9c846a8f8cbd9574db8d76b0a61410a087bc07d53682a54f4\n",
      "  Building wheel for cbor (pyproject.toml): started\n",
      "  Building wheel for cbor (pyproject.toml): finished with status 'done'\n",
      "  Created wheel for cbor: filename=cbor-1.0.0-py3-none-any.whl size=10086 sha256=1612a9d20a54c40d7ecceb2e7bfab4940ebcc00c20388191c4eed9023169bd84\n",
      "  Stored in directory: c:\\users\\skax\\appdata\\local\\pip\\cache\\wheels\\21\\6b\\45\\0c34253b1af07d1d9dc524f6d44d74a6b191c43152e6aaf641\n",
      "  Building wheel for warc3-wet-clueweb09 (pyproject.toml): started\n",
      "  Building wheel for warc3-wet-clueweb09 (pyproject.toml): finished with status 'done'\n",
      "  Created wheel for warc3-wet-clueweb09: filename=warc3_wet_clueweb09-0.2.5-py3-none-any.whl size=19021 sha256=f57289ce457bd072e30f554a4082aa7924327723077097d39a69b9acb1da2fcc\n",
      "  Stored in directory: c:\\users\\skax\\appdata\\local\\pip\\cache\\wheels\\63\\f9\\dc\\2dd16d3330e327236e4d407941975c42d5159d200cdb7922d8\n",
      "Successfully built FlagEmbedding cbor warc3-wet-clueweb09\n",
      "Installing collected packages: warc3-wet-clueweb09, warc3-wet, cbor, zlib-state, unlzw3, trec-car-tools, sentencepiece, pypdf, pybase64, ijson, posthog, inscriptis, ir-datasets, accelerate, peft, FlagEmbedding, chromadb\n",
      "\n",
      "   ---- -----------------------------------  2/17 [cbor]\n",
      "   ----------- ----------------------------  5/17 [trec-car-tools]\n",
      "  Attempting uninstall: pypdf\n",
      "   ----------- ----------------------------  5/17 [trec-car-tools]\n",
      "    Found existing installation: pypdf 4.3.1\n",
      "   ----------- ----------------------------  5/17 [trec-car-tools]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "    Uninstalling pypdf-4.3.1:\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "      Successfully uninstalled pypdf-4.3.1\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ---------------- -----------------------  7/17 [pypdf]\n",
      "   ------------------ ---------------------  8/17 [pybase64]\n",
      "   --------------------- ------------------  9/17 [ijson]\n",
      "  Attempting uninstall: posthog\n",
      "   --------------------- ------------------  9/17 [ijson]\n",
      "    Found existing installation: posthog 6.7.8\n",
      "   --------------------- ------------------  9/17 [ijson]\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "    Uninstalling posthog-6.7.8:\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "      Successfully uninstalled posthog-6.7.8\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "   ----------------------- ---------------- 10/17 [posthog]\n",
      "   ------------------------- -------------- 11/17 [inscriptis]\n",
      "   ------------------------- -------------- 11/17 [inscriptis]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ---------------------------- ----------- 12/17 [ir-datasets]\n",
      "   ------------------------------ --------- 13/17 [accelerate]\n",
      "   ------------------------------ --------- 13/17 [accelerate]\n",
      "   ------------------------------ --------- 13/17 [accelerate]\n",
      "   ------------------------------ --------- 13/17 [accelerate]\n",
      "   ------------------------------ --------- 13/17 [accelerate]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   -------------------------------- ------- 14/17 [peft]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "  Attempting uninstall: chromadb\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "    Found existing installation: chromadb 0.4.24\n",
      "   ----------------------------------- ---- 15/17 [FlagEmbedding]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "    Uninstalling chromadb-0.4.24:\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "      Successfully uninstalled chromadb-0.4.24\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ------------------------------------- -- 16/17 [chromadb]\n",
      "   ---------------------------------------- 17/17 [chromadb]\n",
      "\n",
      "Successfully installed FlagEmbedding-1.3.5 accelerate-1.11.0 cbor-1.0.0 chromadb-1.2.1 ijson-3.4.0.post0 inscriptis-2.6.0 ir-datasets-0.5.11 peft-0.17.1 posthog-5.4.0 pybase64-1.4.2 pypdf-6.1.2 sentencepiece-0.2.1 trec-car-tools-2.6 unlzw3-0.2.3 warc3-wet-0.2.5 warc3-wet-clueweb09-0.2.5 zlib-state-0.1.10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "ERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
      "langchain-chroma 0.1.4 requires chromadb!=0.5.4,!=0.5.5,<0.6.0,>=0.4.0, but you have chromadb 1.2.1 which is incompatible.\n",
      "langchain-chroma 0.1.4 requires numpy<2,>=1; python_version < \"3.12\", but you have numpy 2.3.4 which is incompatible.\n",
      "langchain-upstage 0.3.0 requires pypdf<5.0.0,>=4.2.0, but you have pypdf 6.1.2 which is incompatible.\n",
      "llama-index-readers-file 0.1.33 requires pypdf<5.0.0,>=4.0.1, but you have pypdf 6.1.2 which is incompatible.\n"
     ]
    }
   ],
   "source": [
    "  # ✅ 설치 셀 (런타임/커널 최초 1회만)\n",
    "!pip install -U chromadb sentence-transformers FlagEmbedding pypdf tqdm\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7d9d0c3a",
   "metadata": {},
   "outputs": [],
   "source": [
    "### 평가기준 생성 에이전트 실행"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1b958bb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Failed to send telemetry event ClientStartEvent: capture() takes 1 positional argument but 3 were given\n",
      "Failed to send telemetry event ClientCreateCollectionEvent: capture() takes 1 positional argument but 3 were given\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "📚 EU AI Act 문서 로딩 중...\n",
      "✅ 784개 조항 로드 완료\n",
      "\n",
      "======================================================================\n",
      "📋 [윤리 평가 지표 생성 Agent] 시작\n",
      "======================================================================\n",
      "🏥 Domain: medical\n",
      "\n",
      "======================================================================\n",
      "📋 투명성 (transparency) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act transparency explainability disclosure information requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "   [3] Page 32: database. In order to maximise the availability and use of the EU database by the public, the EU dat...\n",
      "\n",
      "✅ 투명성 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. AI 시스템의 고위험 분류\n",
      "   2. 투명한 정보 제공\n",
      "   3. 데이터 보호 준수\n",
      "   4. 위험 평가 및 관리\n",
      "   5. EU 데이터베이스 등록\n",
      "\n",
      "======================================================================\n",
      "📋 인간 감독 (human_oversight) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act human oversight supervision intervention control requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [3] Page 130: (h)cybersecur ity measures put in place;\n",
      "3. Detailed information about the monitoring, functioning a...\n",
      "\n",
      "✅ 인간 감독 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 인간 감독의 적절성\n",
      "   2. AI 시스템의 정확성\n",
      "   3. 위험 평가 및 관리\n",
      "   4. 데이터의 적절성\n",
      "   5. 모니터링 및 기록 유지\n",
      "\n",
      "======================================================================\n",
      "📋 데이터 거버넌스 (data_governance) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act data quality bias training dataset privacy requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [2] Page 19: validation and testing of AI syste ms.\n",
      "(69) The right to privacy and to protection of personal data ...\n",
      "   [3] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "\n",
      "✅ 데이터 거버넌스 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 공공 안전 및 건강 보호\n",
      "   2. 데이터 보호 및 개인 정보 보장\n",
      "   3. 편향 및 차별 방지\n",
      "   4. 고품질 데이터 사용\n",
      "   5. 위험 관리 및 투명성\n",
      "\n",
      "======================================================================\n",
      "📋 정확도 검증 (accuracy_validation) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accuracy performance validation testing evaluation requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 18: human oversight, and robustness, accuracy and cybersecur ity. Those requirements are necessar y to e...\n",
      "   [3] Page 129: accordance with Article 13(3), point (d);\n",
      "(f)where applicable, a detailed descr iption of pre-deter ...\n",
      "\n",
      "✅ 정확도 검증 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 정확도 측정 기준\n",
      "   2. 데이터 품질 기준\n",
      "   3. 위험 관리 기준\n",
      "   4. 인간 감독 기준\n",
      "   5. 규정 준수 기준\n",
      "\n",
      "======================================================================\n",
      "📋 책임성 (accountability) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accountability liability responsibility redress requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 54: (i)effective measures of redress in relation to the risks posed by an AI syste m, with the exclusion...\n",
      "   [3] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "\n",
      "✅ 책임성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 위험 평가 및 관리\n",
      "   2. EU 적합성 선언\n",
      "   3. 데이터 보호 준수\n",
      "   4. 비차별성 보장\n",
      "   5. 효과적인 구제 조치\n",
      "   6. 응급 서비스 우선 순위 결정\n",
      "\n",
      "======================================================================\n",
      "🎉 평가 지표 생성 완료!\n",
      "======================================================================\n",
      "📊 통계:\n",
      "   - 카테고리: 5개\n",
      "   - 총 평가 기준: 26개\n",
      "   - Domain: medical\n",
      "\n",
      "투명성: 5개 기준\n",
      "  1. AI 시스템의 고위험 분류\n",
      "  2. 투명한 정보 제공\n",
      "  3. 데이터 보호 준수\n",
      "  4. 위험 평가 및 관리\n",
      "  5. EU 데이터베이스 등록\n",
      "\n",
      "인간 감독: 5개 기준\n",
      "  1. 인간 감독의 적절성\n",
      "  2. AI 시스템의 정확성\n",
      "  3. 위험 평가 및 관리\n",
      "  4. 데이터의 적절성\n",
      "  5. 모니터링 및 기록 유지\n",
      "\n",
      "데이터 거버넌스: 5개 기준\n",
      "  1. 공공 안전 및 건강 보호\n",
      "  2. 데이터 보호 및 개인 정보 보장\n",
      "  3. 편향 및 차별 방지\n",
      "  4. 고품질 데이터 사용\n",
      "  5. 위험 관리 및 투명성\n",
      "\n",
      "정확도 검증: 5개 기준\n",
      "  1. 정확도 측정 기준\n",
      "  2. 데이터 품질 기준\n",
      "  3. 위험 관리 기준\n",
      "  4. 인간 감독 기준\n",
      "  5. 규정 준수 기준\n",
      "\n",
      "책임성: 6개 기준\n",
      "  1. 위험 평가 및 관리\n",
      "  2. EU 적합성 선언\n",
      "  3. 데이터 보호 준수\n",
      "  4. 비차별성 보장\n",
      "  5. 효과적인 구제 조치\n",
      "  6. 응급 서비스 우선 순위 결정\n"
     ]
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "from state_schema import create_initial_state\n",
    "from agents import EthicsCriteriaGenerator\n",
    "\n",
    "# State 생성\n",
    "state = create_initial_state(\"Vara\", \"medical\")\n",
    "\n",
    "# Agent 실행\n",
    "generator = EthicsCriteriaGenerator(openai_api_key=os.getenv(\"OPENAI_API_KEY\"))\n",
    "state = generator.execute(state)\n",
    "\n",
    "# 결과 확인\n",
    "criteria = state[\"ethics_evaluation_criteria\"]\n",
    "for cat_key, cat_data in criteria['categories'].items():\n",
    "    print(f\"\\n{cat_data['category']}: {len(cat_data['criteria'])}개 기준\")\n",
    "    for i, crit in enumerate(cat_data['criteria'], 1):\n",
    "        print(f\"  {i}. {crit['title']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "8aabc5d1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "======================================================================\n",
      "🌐 [웹 정보 수집 Agent] 시작 (자가 게이트/루프)\n",
      "======================================================================\n",
      "\n",
      "🔁 수집 시도 1/2\n",
      "🔍 Tavily 검색 중 (총 10개 쿼리)...\n",
      "  ✓ 'Vara medical company overview' [basic] → 5개\n",
      "  ✓ 'Vara product features technology' [basic] → 5개\n",
      "  ✓ 'Vara news press release' [basic] → 5개\n",
      "  ✓ 'Vara case study' [basic] → 5개\n",
      "  ✓ 'Vara whitepaper' [basic] → 5개\n",
      "  ✓ 'Vara interview' [basic] → 5개\n",
      "  ✓ 'Vara site:medium.com' [basic] → 5개\n",
      "  ✓ 'Vara site:github.com' [basic] → 4개\n",
      "  ✓ 'Vara site:linkedin.com' [basic] → 4개\n",
      "  ✓ 'Vara funding announcement' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 48개\n",
      "📈 추가 심층 검색 실행 중...\n",
      "  ✓ 'Vara medical company overview' [advanced] → 8개\n",
      "  ✓ 'Vara product features technology' [advanced] → 8개\n",
      "  ✓ 'Vara news press release' [advanced] → 8개\n",
      "  ✓ 'Vara case study' [advanced] → 8개\n",
      "  ✓ 'Vara whitepaper' [advanced] → 8개\n",
      "📊 2차 수집(중복 포함 누계): 88개\n",
      "🌈 도메인 캡 후: 88개  (host≤15, 호스트수=49)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 88개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'reliability']\n",
      "\n",
      "🔁 수집 시도 2/2\n",
      "🔍 Tavily 검색 중 (총 19개 쿼리)...\n",
      "  ✓ 'Vara medical company overview' [basic] → 5개\n",
      "  ✓ 'Vara product features technology' [basic] → 5개\n",
      "  ✓ 'Vara news press release' [basic] → 5개\n",
      "  ✓ 'Vara case study' [basic] → 5개\n",
      "  ✓ 'Vara whitepaper' [basic] → 5개\n",
      "  ✓ 'Vara interview' [basic] → 5개\n",
      "  ✓ 'Vara site:medium.com' [basic] → 5개\n",
      "  ✓ 'Vara site:github.com' [basic] → 4개\n",
      "  ✓ 'Vara site:linkedin.com' [basic] → 4개\n",
      "  ✓ 'Vara funding announcement' [basic] → 5개\n",
      "  ✓ 'Vara site:vara.com (press OR newsroom OR investors)' [basic] → 5개\n",
      "  ✓ 'Vara press release site:vara.com' [basic] → 5개\n",
      "  ✓ 'Vara site:vara.com blog' [basic] → 5개\n",
      "  ✓ 'Vara site:sec.gov OR site:europa.eu OR site:ec.europa.eu' [basic] → 5개\n",
      "  ✓ 'Vara site:iso.org OR site:ieee.org standard' [basic] → 5개\n",
      "  ✓ 'Vara analyst report site:gartner.com OR site:forrester.com' [basic] → 5개\n",
      "  ✓ 'Vara review technology analysis' [basic] → 5개\n",
      "  ✓ 'Vara medical industry report' [basic] → 5개\n",
      "  ✓ 'Vara competitors comparison' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 93개\n",
      "📈 추가 심층 검색 실행 중...\n",
      "  ✓ 'Vara medical company overview' [advanced] → 8개\n",
      "  ✓ 'Vara product features technology' [advanced] → 8개\n",
      "  ✓ 'Vara news press release' [advanced] → 8개\n",
      "  ✓ 'Vara case study' [advanced] → 8개\n",
      "  ✓ 'Vara whitepaper' [advanced] → 8개\n",
      "📊 2차 수집(중복 포함 누계): 133개\n",
      "🌈 도메인 캡 후: 133개  (host≤15, 호스트수=72)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 133개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'reliability']\n",
      "⛔ 최대 시도 도달. partial로 종료합니다.\n",
      "\n",
      "📦 최종 상태: partial / 문서 108개\n",
      "\n",
      "======================================================================\n",
      "🎓 [전문 자료 수집 Agent] 시작\n",
      "======================================================================\n",
      "🔬 학술 논문 검색 중: Vara\n",
      "  ✓ 'Vara AI medical clinical validation study...' → 5개\n",
      "  ✓ 'Vara algorithm accuracy peer reviewed...' → 5개\n",
      "  ✓ 'Vara medical machine learning research...' → 5개\n",
      "  ✓ 'Vara diagnostic accuracy study...' → 5개\n",
      "  ✓ 'Vara medical clinical trial results...' → 5개\n",
      "  ✓ 'Vara AI medical imaging validation...' → 5개\n",
      "  ✓ 'Vara medical retrospective study...' → 5개\n",
      "  ✓ 'Vara algorithm performance evaluation...' → 5개\n",
      "📚 학술 논문 총 40개 수집\n",
      "📋 규제 문서 검색 중: Vara\n",
      "  ✓ 'Vara FDA approval CE mark...' → 10개\n",
      "  ✓ 'Vara EU MDR medical device...' → 10개\n",
      "  ✓ 'Vara FDA 510k clearance...' → 10개\n",
      "  ✓ 'Vara CE marking certificate...' → 10개\n",
      "  ✓ 'Vara medical device regulation approval...' → 10개\n",
      "  ✓ 'Vara regulatory submission documentation...' → 10개\n",
      "📋 규제 문서 총 60개 수집\n",
      "🧪 임상시험 데이터 검색 중: Vara\n",
      "  ✓ 'Vara clinical trial medical...' → 5개\n",
      "  ✓ 'Vara clinicaltrials.gov study...' → 5개\n",
      "  ✓ 'Vara medical trial results...' → 5개\n",
      "  ✓ 'Vara multicenter trial...' → 5개\n",
      "🧪 임상시험 데이터 총 20개 수집\n",
      "✅ 전문 자료 수집 완료: 120개 문서\n",
      "  📚 학술 논문: 40개\n",
      "  📋 규제 문서: 60개\n",
      "  🧪 임상시험: 20개\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Failed to send telemetry event ClientStartEvent: capture() takes 1 positional argument but 3 were given\n",
      "Failed to send telemetry event ClientCreateCollectionEvent: capture() takes 1 positional argument but 3 were given\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "📚 EU AI Act 문서 로딩 중...\n",
      "✅ 784개 조항 로드 완료\n",
      "\n",
      "======================================================================\n",
      "📋 [윤리 평가 지표 생성 Agent] 시작\n",
      "======================================================================\n",
      "🏥 Domain: medical\n",
      "\n",
      "======================================================================\n",
      "📋 투명성 (transparency) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act transparency explainability disclosure information requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "   [3] Page 32: database. In order to maximise the availability and use of the EU database by the public, the EU dat...\n",
      "\n",
      "✅ 투명성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. AI 시스템의 고위험 분류\n",
      "   2. 투명한 정보 제공\n",
      "   3. 데이터 보호 준수\n",
      "   4. 위험 평가 및 관리 절차\n",
      "   5. EU 데이터베이스 등록\n",
      "   6. 사용자 피드백 메커니즘\n",
      "\n",
      "======================================================================\n",
      "📋 인간 감독 (human_oversight) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act human oversight supervision intervention control requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [3] Page 130: (h)cybersecur ity measures put in place;\n",
      "3. Detailed information about the monitoring, functioning a...\n",
      "\n",
      "✅ 인간 감독 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 인간 감독의 적절성\n",
      "   2. AI 시스템의 정확성 평가\n",
      "   3. 위험 평가 및 관리\n",
      "   4. 데이터의 적절성 및 대표성\n",
      "   5. 모니터링 및 기록 유지\n",
      "\n",
      "======================================================================\n",
      "📋 데이터 거버넌스 (data_governance) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act data quality bias training dataset privacy requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [2] Page 19: validation and testing of AI syste ms.\n",
      "(69) The right to privacy and to protection of personal data ...\n",
      "   [3] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "\n",
      "✅ 데이터 거버넌스 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 공공 안전 및 건강 보호\n",
      "   2. 데이터 보호 및 개인 정보 보장\n",
      "   3. 편향 및 차별 방지\n",
      "   4. 고품질 데이터 사용\n",
      "   5. 위험 관리 및 투명성\n",
      "\n",
      "======================================================================\n",
      "📋 정확도 검증 (accuracy_validation) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accuracy performance validation testing evaluation requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 18: human oversight, and robustness, accuracy and cybersecur ity. Those requirements are necessar y to e...\n",
      "   [3] Page 129: accordance with Article 13(3), point (d);\n",
      "(f)where applicable, a detailed descr iption of pre-deter ...\n",
      "\n",
      "✅ 정확도 검증 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 정확도 측정 기준\n",
      "   2. 데이터 품질 기준\n",
      "   3. 위험 관리 기준\n",
      "   4. 인간 감독 기준\n",
      "   5. 규정 준수 기준\n",
      "\n",
      "======================================================================\n",
      "📋 책임성 (accountability) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accountability liability responsibility redress requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 54: (i)effective measures of redress in relation to the risks posed by an AI syste m, with the exclusion...\n",
      "   [3] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "\n",
      "✅ 책임성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 위험 평가 및 관리\n",
      "   2. EU 적합성 선언\n",
      "   3. 데이터 보호 준수\n",
      "   4. 비차별성 보장\n",
      "   5. 효과적인 구제 조치\n",
      "   6. 결과의 수정 가능성\n",
      "\n",
      "======================================================================\n",
      "🎉 평가 지표 생성 완료!\n",
      "======================================================================\n",
      "📊 통계:\n",
      "   - 카테고리: 5개\n",
      "   - 총 평가 기준: 27개\n",
      "   - Domain: medical\n",
      "\n",
      "======================================================================\n",
      "⚖️ [윤리 평가 실행 Agent] 시작\n",
      "======================================================================\n",
      "✅ 평가 기준 로드: 27개\n",
      "📚 평가 대상 문서:\n",
      "   - 웹 수집: 108개\n",
      "   - 전문 자료: 120개\n",
      "   - 총: 228개\n",
      "\n",
      "======================================================================\n",
      "📋 TRANSPARENCY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 62.5/100\n",
      "   신뢰도: 0.70\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 HUMAN_OVERSIGHT 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 55/100\n",
      "   신뢰도: 0.60\n",
      "   근거: 2개\n",
      "   이슈: 2개\n",
      "   강점: 1개\n",
      "\n",
      "======================================================================\n",
      "📋 DATA_GOVERNANCE 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 76/100\n",
      "   신뢰도: 0.80\n",
      "   근거: 5개\n",
      "   이슈: 4개\n",
      "   강점: 1개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCURACY_VALIDATION 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 62.5/100\n",
      "   신뢰도: 0.70\n",
      "   근거: 5개\n",
      "   이슈: 5개\n",
      "   강점: 1개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCOUNTABILITY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 45/100\n",
      "   신뢰도: 0.60\n",
      "   근거: 6개\n",
      "   이슈: 2개\n",
      "   강점: 1개\n",
      "\n",
      "✅ 윤리 평가 완료\n",
      "\n",
      "======================================================================\n",
      "🎉 윤리 평가 완료!\n",
      "======================================================================\n",
      "📊 최종 점수: 60.0/100 (등급: C)\n",
      "💡 전체 신뢰도: 0.68\n",
      "⚠️ Critical Issues: 2개\n",
      "📝 총 근거: 24개\n",
      "점수: 60.0/100\n"
     ]
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "load_dotenv()\n",
    "TAVILY_API_KEY = os.getenv(\"TAVILY_API_KEY\")\n",
    "OPENAI_API_KEY = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "from state_schema import create_initial_state\n",
    "from agents import WebCollectionAgent, SpecializedCollectionAgent\n",
    "from agents.ethics_criteria_generator import EthicsCriteriaGenerator\n",
    "from agents.ethics_evaluator import EthicsEvaluator\n",
    "\n",
    "# State 생성 (Cell 2)\n",
    "state = create_initial_state(\"Vara\", \"medical\")\n",
    "\n",
    "# 수집 (Cell 3-4)\n",
    "web_agent = WebCollectionAgent(\n",
    "    tavily_api_key=os.getenv(\"TAVILY_API_KEY\"),\n",
    "    openai_api_key=os.getenv(\"OPENAI_API_KEY\"))\n",
    "state = web_agent.execute(state)\n",
    "\n",
    "spec_agent = SpecializedCollectionAgent(\n",
    "    tavily_api_key=os.getenv(\"TAVILY_API_KEY\"),\n",
    "    openai_api_key=os.getenv(\"OPENAI_API_KEY\")\n",
    ")\n",
    "state = spec_agent.execute(state)\n",
    "\n",
    "\n",
    "# 평가 기준 생성 (Cell 5)\n",
    "generator = EthicsCriteriaGenerator(openai_api_key=os.getenv(\"OPENAI_API_KEY\"))\n",
    "state = generator.execute(state)\n",
    "\n",
    "# 평가 실행 (Cell 6)\n",
    "evaluator = EthicsEvaluator(openai_api_key=OPENAI_API_KEY)\n",
    "state = evaluator.execute(state)\n",
    "\n",
    "# 결과 확인 (Cell 7)\n",
    "print(f\"점수: {state['ethics_score']['total']}/100\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c205049b",
   "metadata": {},
   "source": [
    "### 전체 파이프라인 실행"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "7b27fda1",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv, find_dotenv\n",
    "import os\n",
    "\n",
    "env_path = find_dotenv()\n",
    "load_dotenv(dotenv_path=env_path, override=True)\n",
    "TAVILY_API_KEY = os.getenv(\"TAVILY_API_KEY\")\n",
    "OPENAI_API_KEY = os.getenv(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "b6b6dfb3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Failed to send telemetry event ClientStartEvent: capture() takes 1 positional argument but 3 were given\n",
      "Failed to send telemetry event ClientCreateCollectionEvent: capture() takes 1 positional argument but 3 were given\n",
      "Failed to send telemetry event CollectionGetEvent: capture() takes 1 positional argument but 3 were given\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "📚 EU AI Act 문서 로딩 중...\n",
      "✅ 784개 조항 로드 완료\n",
      "✅ 한글 폰트 로드 완료: C:\\Windows\\Fonts\\malgun.ttf\n",
      "\n",
      "======================================================================\n",
      "🚀 윤리 평가 파이프라인 시작\n",
      "======================================================================\n",
      "회사: Babylon Health\n",
      "도메인: medical\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "🌐 [Node 1/6] 웹 정보 수집\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "🌐 [웹 정보 수집 Agent] 시작 (자가 게이트/루프)\n",
      "======================================================================\n",
      "\n",
      "🔁 수집 시도 1/2\n",
      "🔍 Tavily 검색 중 (총 10개 쿼리)...\n",
      "  ✓ 'Babylon Health medical company overview' [basic] → 5개\n",
      "  ✓ 'Babylon Health product features technology' [basic] → 5개\n",
      "  ✓ 'Babylon Health news press release' [basic] → 5개\n",
      "  ✓ 'Babylon Health case study' [basic] → 5개\n",
      "  ✓ 'Babylon Health whitepaper' [basic] → 5개\n",
      "  ✓ 'Babylon Health interview' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:medium.com' [basic] → 4개\n",
      "  ✓ 'Babylon Health site:github.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:linkedin.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health funding announcement' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 49개\n",
      "📈 추가 심층 검색 실행 중...\n",
      "  ✓ 'Babylon Health medical company overview' [advanced] → 8개\n",
      "  ✓ 'Babylon Health product features technology' [advanced] → 8개\n",
      "  ✓ 'Babylon Health news press release' [advanced] → 8개\n",
      "  ✓ 'Babylon Health case study' [advanced] → 8개\n",
      "  ✓ 'Babylon Health whitepaper' [advanced] → 8개\n",
      "📊 2차 수집(중복 포함 누계): 89개\n",
      "🌈 도메인 캡 후: 89개  (host≤15, 호스트수=50)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 89개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'recent', 'reliability']\n",
      "\n",
      "🔁 수집 시도 2/2\n",
      "🔍 Tavily 검색 중 (총 21개 쿼리)...\n",
      "  ✓ 'Babylon Health medical company overview' [basic] → 5개\n",
      "  ✓ 'Babylon Health product features technology' [basic] → 5개\n",
      "  ✓ 'Babylon Health news press release' [basic] → 5개\n",
      "  ✓ 'Babylon Health case study' [basic] → 5개\n",
      "  ✓ 'Babylon Health whitepaper' [basic] → 5개\n",
      "  ✓ 'Babylon Health interview' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:medium.com' [basic] → 4개\n",
      "  ✓ 'Babylon Health site:github.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:linkedin.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health funding announcement' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:babylonhealth.com (press OR newsroom OR investors)' [basic] → 3개\n",
      "  ✓ 'Babylon Health press release site:babylonhealth.com' [basic] → 3개\n",
      "  ✓ 'Babylon Health site:babylonhealth.com blog' [basic] → 5개\n",
      "  ✓ 'Babylon Health (\"launch\" OR \"announced\" OR \"funding\") after:2025-04-26' [basic] → 5개\n",
      "  ✓ 'Babylon Health press release after:2025-04-26' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:sec.gov OR site:europa.eu OR site:ec.europa.eu' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:iso.org OR site:ieee.org standard' [basic] → 5개\n",
      "  ✓ 'Babylon Health analyst report site:gartner.com OR site:forrester.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health review technology analysis' [basic] → 5개\n",
      "  ✓ 'Babylon Health medical industry report' [basic] → 5개\n",
      "  ✓ 'Babylon Health competitors comparison' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 100개\n",
      "📊 2차 수집(중복 포함 누계): 100개\n",
      "🌈 도메인 캡 후: 100개  (host≤15, 호스트수=61)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 100개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'recent', 'reliability']\n",
      "⛔ 최대 시도 도달. partial로 종료합니다.\n",
      "\n",
      "📦 최종 상태: partial / 문서 99개\n",
      "\n",
      "======================================================================\n",
      "🎓 [Node 2/6] 전문 자료 수집\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "🎓 [전문 자료 수집 Agent] 시작\n",
      "======================================================================\n",
      "🔬 학술 논문 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health AI medical clinical validation stud...' → 5개\n",
      "  ✓ 'Babylon Health algorithm accuracy peer reviewed...' → 5개\n",
      "  ✓ 'Babylon Health medical machine learning research...' → 5개\n",
      "  ✓ 'Babylon Health diagnostic accuracy study...' → 5개\n",
      "  ✓ 'Babylon Health medical clinical trial results...' → 5개\n",
      "  ✓ 'Babylon Health AI medical imaging validation...' → 5개\n",
      "  ✓ 'Babylon Health medical retrospective study...' → 5개\n",
      "  ✓ 'Babylon Health algorithm performance evaluation...' → 5개\n",
      "📚 학술 논문 총 40개 수집\n",
      "📋 규제 문서 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health FDA approval CE mark...' → 10개\n",
      "  ✓ 'Babylon Health EU MDR medical device...' → 5개\n",
      "  ✓ 'Babylon Health FDA 510k clearance...' → 10개\n",
      "  ✓ 'Babylon Health CE marking certificate...' → 10개\n",
      "  ✓ 'Babylon Health medical device regulation approval...' → 10개\n",
      "  ✓ 'Babylon Health regulatory submission documentation...' → 10개\n",
      "📋 규제 문서 총 55개 수집\n",
      "🧪 임상시험 데이터 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health clinical trial medical...' → 5개\n",
      "  ✓ 'Babylon Health clinicaltrials.gov study...' → 5개\n",
      "  ✓ 'Babylon Health medical trial results...' → 5개\n",
      "  ✓ 'Babylon Health multicenter trial...' → 5개\n",
      "🧪 임상시험 데이터 총 20개 수집\n",
      "✅ 전문 자료 수집 완료: 115개 문서\n",
      "  📚 학술 논문: 40개\n",
      "  📋 규제 문서: 55개\n",
      "  🧪 임상시험: 20개\n",
      "\n",
      "======================================================================\n",
      "📋 [Node 3/6] 평가 기준 생성\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "📋 [윤리 평가 지표 생성 Agent] 시작\n",
      "======================================================================\n",
      "🏥 Domain: medical\n",
      "\n",
      "======================================================================\n",
      "📋 투명성 (transparency) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act transparency explainability disclosure information requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "   [3] Page 32: database. In order to maximise the availability and use of the EU database by the public, the EU dat...\n",
      "\n",
      "✅ 투명성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. AI 시스템의 고위험 분류\n",
      "   2. 투명한 정보 제공\n",
      "   3. 데이터 보호 준수\n",
      "   4. 위험 평가 및 관리\n",
      "   5. 사용자 피드백 메커니즘\n",
      "   6. AI 시스템의 등록 및 공개\n",
      "\n",
      "======================================================================\n",
      "📋 인간 감독 (human_oversight) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act human oversight supervision intervention control requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [3] Page 130: (h)cybersecur ity measures put in place;\n",
      "3. Detailed information about the monitoring, functioning a...\n",
      "\n",
      "✅ 인간 감독 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 인간 감독의 적절성\n",
      "   2. AI 시스템의 정확성 평가\n",
      "   3. 위험 평가 및 관리\n",
      "   4. 데이터의 적절성 및 대표성\n",
      "   5. 모니터링 및 기록 유지\n",
      "\n",
      "======================================================================\n",
      "📋 데이터 거버넌스 (data_governance) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act data quality bias training dataset privacy requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [2] Page 19: validation and testing of AI syste ms.\n",
      "(69) The right to privacy and to protection of personal data ...\n",
      "   [3] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "\n",
      "✅ 데이터 거버넌스 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 데이터 품질 보장\n",
      "   2. 개인정보 보호 준수\n",
      "   3. 편향 및 차별 방지\n",
      "   4. 위험 관리 절차\n",
      "   5. 투명성 및 정보 제공\n",
      "   6. 인간 감독 및 개입\n",
      "\n",
      "======================================================================\n",
      "📋 정확도 검증 (accuracy_validation) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accuracy performance validation testing evaluation requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 18: human oversight, and robustness, accuracy and cybersecur ity. Those requirements are necessar y to e...\n",
      "   [3] Page 129: accordance with Article 13(3), point (d);\n",
      "(f)where applicable, a detailed descr iption of pre-deter ...\n",
      "\n",
      "✅ 정확도 검증 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 정확도 측정 지표\n",
      "   2. 데이터 품질 평가\n",
      "   3. 위험 관리 시스템 검토\n",
      "   4. 인간 감독 절차 검토\n",
      "   5. 테스트 및 검증 절차\n",
      "   6. 차별적 영향 평가\n",
      "\n",
      "======================================================================\n",
      "📋 책임성 (accountability) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accountability liability responsibility redress requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 54: (i)effective measures of redress in relation to the risks posed by an AI syste m, with the exclusion...\n",
      "   [3] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "\n",
      "✅ 책임성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 위험 평가 및 관리\n",
      "   2. EU 적합성 선언\n",
      "   3. 데이터 보호 준수\n",
      "   4. 비차별성 보장\n",
      "   5. 효과적인 구제 조치\n",
      "   6. 결과의 수정 가능성\n",
      "\n",
      "======================================================================\n",
      "🎉 평가 지표 생성 완료!\n",
      "======================================================================\n",
      "📊 통계:\n",
      "   - 카테고리: 5개\n",
      "   - 총 평가 기준: 29개\n",
      "   - Domain: medical\n",
      "\n",
      "======================================================================\n",
      "⚖️ [Node 4/6] 윤리 평가 수행\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "⚖️ [윤리 평가 실행 Agent] 시작\n",
      "======================================================================\n",
      "✅ 평가 기준 로드: 29개\n",
      "📚 평가 대상 문서:\n",
      "   - 웹 수집: 99개\n",
      "   - 전문 자료: 115개\n",
      "   - 총: 214개\n",
      "\n",
      "======================================================================\n",
      "📋 TRANSPARENCY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 30/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 HUMAN_OVERSIGHT 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25.0/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 5개\n",
      "   이슈: 5개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 DATA_GOVERNANCE 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCURACY_VALIDATION 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCOUNTABILITY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "  → 전체 신뢰도 부족: 0.50 < 0.6\n",
      "\n",
      "⚠️ 정보 부족으로 재수집 필요\n",
      "\n",
      "======================================================================\n",
      "🎉 윤리 평가 완료!\n",
      "======================================================================\n",
      "📊 최종 점수: 26.0/100 (등급: D)\n",
      "💡 전체 신뢰도: 0.50\n",
      "⚠️ Critical Issues: 29개\n",
      "📝 총 근거: 29개\n",
      "\n",
      "======================================================================\n",
      "🔍 재수집 필요 여부 확인\n",
      "======================================================================\n",
      "⚠️ 재수집 필요 (시도 횟수: 1)\n",
      "집중 영역: []\n",
      "\n",
      "======================================================================\n",
      "🌐 [Node 1/6] 웹 정보 수집\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "🌐 [웹 정보 수집 Agent] 시작 (자가 게이트/루프)\n",
      "======================================================================\n",
      "\n",
      "🔁 수집 시도 1/2\n",
      "🔍 Tavily 검색 중 (총 10개 쿼리)...\n",
      "  ✓ 'Babylon Health medical company overview' [basic] → 5개\n",
      "  ✓ 'Babylon Health product features technology' [basic] → 5개\n",
      "  ✓ 'Babylon Health news press release' [basic] → 5개\n",
      "  ✓ 'Babylon Health case study' [basic] → 5개\n",
      "  ✓ 'Babylon Health whitepaper' [basic] → 5개\n",
      "  ✓ 'Babylon Health interview' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:medium.com' [basic] → 4개\n",
      "  ✓ 'Babylon Health site:github.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:linkedin.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health funding announcement' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 49개\n",
      "📈 추가 심층 검색 실행 중...\n",
      "  ✓ 'Babylon Health medical company overview' [advanced] → 8개\n",
      "  ✓ 'Babylon Health product features technology' [advanced] → 8개\n",
      "  ✓ 'Babylon Health news press release' [advanced] → 8개\n",
      "  ✓ 'Babylon Health case study' [advanced] → 8개\n",
      "  ✓ 'Babylon Health whitepaper' [advanced] → 8개\n",
      "📊 2차 수집(중복 포함 누계): 89개\n",
      "🌈 도메인 캡 후: 89개  (host≤15, 호스트수=50)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 89개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'recent', 'reliability']\n",
      "\n",
      "🔁 수집 시도 2/2\n",
      "🔍 Tavily 검색 중 (총 21개 쿼리)...\n",
      "  ✓ 'Babylon Health medical company overview' [basic] → 5개\n",
      "  ✓ 'Babylon Health product features technology' [basic] → 5개\n",
      "  ✓ 'Babylon Health news press release' [basic] → 5개\n",
      "  ✓ 'Babylon Health case study' [basic] → 5개\n",
      "  ✓ 'Babylon Health whitepaper' [basic] → 5개\n",
      "  ✓ 'Babylon Health interview' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:medium.com' [basic] → 4개\n",
      "  ✓ 'Babylon Health site:github.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:linkedin.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health funding announcement' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:babylonhealth.com (press OR newsroom OR investors)' [basic] → 3개\n",
      "  ✓ 'Babylon Health press release site:babylonhealth.com' [basic] → 3개\n",
      "  ✓ 'Babylon Health site:babylonhealth.com blog' [basic] → 5개\n",
      "  ✓ 'Babylon Health (\"launch\" OR \"announced\" OR \"funding\") after:2025-04-26' [basic] → 5개\n",
      "  ✓ 'Babylon Health press release after:2025-04-26' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:sec.gov OR site:europa.eu OR site:ec.europa.eu' [basic] → 5개\n",
      "  ✓ 'Babylon Health site:iso.org OR site:ieee.org standard' [basic] → 5개\n",
      "  ✓ 'Babylon Health analyst report site:gartner.com OR site:forrester.com' [basic] → 5개\n",
      "  ✓ 'Babylon Health review technology analysis' [basic] → 5개\n",
      "  ✓ 'Babylon Health medical industry report' [basic] → 5개\n",
      "  ✓ 'Babylon Health competitors comparison' [basic] → 5개\n",
      "📊 1차 수집(중복 포함): 100개\n",
      "📊 2차 수집(중복 포함 누계): 100개\n",
      "🌈 도메인 캡 후: 100개  (host≤15, 호스트수=61)\n",
      "🤖 LLM으로 문서 분석 중...\n",
      "✅ 100개 문서 분석 완료\n",
      "⚠️ 게이트 미통과 → 부족 슬롯: ['diversity', 'primary', 'recent', 'reliability']\n",
      "⛔ 최대 시도 도달. partial로 종료합니다.\n",
      "\n",
      "📦 최종 상태: partial / 문서 99개\n",
      "\n",
      "======================================================================\n",
      "🎓 [Node 2/6] 전문 자료 수집\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "🎓 [전문 자료 수집 Agent] 시작\n",
      "======================================================================\n",
      "🔬 학술 논문 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health AI medical clinical validation stud...' → 5개\n",
      "  ✓ 'Babylon Health algorithm accuracy peer reviewed...' → 5개\n",
      "  ✓ 'Babylon Health medical machine learning research...' → 5개\n",
      "  ✓ 'Babylon Health diagnostic accuracy study...' → 5개\n",
      "  ✓ 'Babylon Health medical clinical trial results...' → 5개\n",
      "  ✓ 'Babylon Health AI medical imaging validation...' → 5개\n",
      "  ✓ 'Babylon Health medical retrospective study...' → 5개\n",
      "  ✓ 'Babylon Health algorithm performance evaluation...' → 5개\n",
      "📚 학술 논문 총 40개 수집\n",
      "📋 규제 문서 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health FDA approval CE mark...' → 10개\n",
      "  ✓ 'Babylon Health EU MDR medical device...' → 5개\n",
      "  ✓ 'Babylon Health FDA 510k clearance...' → 10개\n",
      "  ✓ 'Babylon Health CE marking certificate...' → 10개\n",
      "  ✓ 'Babylon Health medical device regulation approval...' → 10개\n",
      "  ✓ 'Babylon Health regulatory submission documentation...' → 10개\n",
      "📋 규제 문서 총 55개 수집\n",
      "🧪 임상시험 데이터 검색 중: Babylon Health\n",
      "  ✓ 'Babylon Health clinical trial medical...' → 5개\n",
      "  ✓ 'Babylon Health clinicaltrials.gov study...' → 5개\n",
      "  ✓ 'Babylon Health medical trial results...' → 5개\n",
      "  ✓ 'Babylon Health multicenter trial...' → 5개\n",
      "🧪 임상시험 데이터 총 20개 수집\n",
      "✅ 전문 자료 수집 완료: 115개 문서\n",
      "  📚 학술 논문: 40개\n",
      "  📋 규제 문서: 55개\n",
      "  🧪 임상시험: 20개\n",
      "\n",
      "======================================================================\n",
      "📋 [Node 3/6] 평가 기준 생성\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "📋 [윤리 평가 지표 생성 Agent] 시작\n",
      "======================================================================\n",
      "🏥 Domain: medical\n",
      "\n",
      "======================================================================\n",
      "📋 투명성 (transparency) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act transparency explainability disclosure information requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "   [3] Page 32: database. In order to maximise the availability and use of the EU database by the public, the EU dat...\n",
      "\n",
      "✅ 투명성 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. AI 시스템의 고위험 분류\n",
      "   2. 투명한 정보 제공\n",
      "   3. 데이터 보호 준수\n",
      "   4. 위험 평가 및 관리\n",
      "   5. EU 데이터베이스 등록\n",
      "\n",
      "======================================================================\n",
      "📋 인간 감독 (human_oversight) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act human oversight supervision intervention control requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [3] Page 130: (h)cybersecur ity measures put in place;\n",
      "3. Detailed information about the monitoring, functioning a...\n",
      "\n",
      "✅ 인간 감독 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 인간 감독의 적절성\n",
      "   2. AI 시스템의 정확성\n",
      "   3. 위험 평가 및 관리\n",
      "   4. 데이터의 적절성\n",
      "   5. 모니터링 및 기록 유지\n",
      "\n",
      "======================================================================\n",
      "📋 데이터 거버넌스 (data_governance) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act data quality bias training dataset privacy requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 90: purpose of developing, training and testing certain AI systems in the sandbo x when all of the follo...\n",
      "   [2] Page 19: validation and testing of AI syste ms.\n",
      "(69) The right to privacy and to protection of personal data ...\n",
      "   [3] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "\n",
      "✅ 데이터 거버넌스 평가 기준:\n",
      "   생성된 기준: 5개\n",
      "   1. 데이터 품질 보장\n",
      "   2. 개인정보 보호 준수\n",
      "   3. 편향 및 차별 방지\n",
      "   4. 위험 관리 및 완화\n",
      "   5. 투명성 및 정보 제공\n",
      "\n",
      "======================================================================\n",
      "📋 정확도 검증 (accuracy_validation) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accuracy performance validation testing evaluation requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 18: human oversight, and robustness, accuracy and cybersecur ity. Those requirements are necessar y to e...\n",
      "   [3] Page 129: accordance with Article 13(3), point (d);\n",
      "(f)where applicable, a detailed descr iption of pre-deter ...\n",
      "\n",
      "✅ 정확도 검증 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. AI 시스템의 정확도 측정\n",
      "   2. 데이터 품질 관리\n",
      "   3. 위험 관리 시스템 문서화\n",
      "   4. 테스트 및 검증 절차\n",
      "   5. 자동 기록 기능\n",
      "   6. 인간 감독의 존재\n",
      "\n",
      "======================================================================\n",
      "📋 책임성 (accountability) 평가 지표 생성 중...\n",
      "======================================================================\n",
      "🔍 검색 쿼리: EU AI Act accountability liability responsibility redress requirements for healthcare medical diagnosis clinical patient safety high-risk AI systems\n",
      "📜 검색된 조항: 10개\n",
      "   [1] Page 16: to be used for risk assessment and pricing in relation to natural persons for health and life insura...\n",
      "   [2] Page 54: (i)effective measures of redress in relation to the risks posed by an AI syste m, with the exclusion...\n",
      "   [3] Page 11: education should be prohibite d. That prohibition should not cover AI systems placed on the mark et ...\n",
      "\n",
      "✅ 책임성 평가 기준:\n",
      "   생성된 기준: 6개\n",
      "   1. 위험 평가 및 관리\n",
      "   2. EU 적합성 선언\n",
      "   3. 데이터 보호 준수\n",
      "   4. 비차별성 보장\n",
      "   5. 효과적인 구제 조치\n",
      "   6. 결과의 수정 가능성\n",
      "\n",
      "======================================================================\n",
      "🎉 평가 지표 생성 완료!\n",
      "======================================================================\n",
      "📊 통계:\n",
      "   - 카테고리: 5개\n",
      "   - 총 평가 기준: 27개\n",
      "   - Domain: medical\n",
      "\n",
      "======================================================================\n",
      "⚖️ [Node 4/6] 윤리 평가 수행\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "⚖️ [윤리 평가 실행 Agent] 시작\n",
      "======================================================================\n",
      "✅ 평가 기준 로드: 27개\n",
      "📚 평가 대상 문서:\n",
      "   - 웹 수집: 99개\n",
      "   - 전문 자료: 115개\n",
      "   - 총: 214개\n",
      "\n",
      "======================================================================\n",
      "📋 TRANSPARENCY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 30/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 5개\n",
      "   이슈: 5개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 HUMAN_OVERSIGHT 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25.0/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 5개\n",
      "   이슈: 5개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 DATA_GOVERNANCE 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 5개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 20/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 5개\n",
      "   이슈: 1개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCURACY_VALIDATION 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 25/100\n",
      "   신뢰도: 0.50\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "\n",
      "======================================================================\n",
      "📋 ACCOUNTABILITY 평가 중...\n",
      "======================================================================\n",
      "📝 평가 기준: 6개\n",
      "\n",
      "📊 평가 결과:\n",
      "   점수: 20/100\n",
      "   신뢰도: 0.20\n",
      "   근거: 6개\n",
      "   이슈: 6개\n",
      "   강점: 0개\n",
      "  → 전체 신뢰도 부족: 0.44 < 0.6\n",
      "\n",
      "⚠️ 정보 부족으로 재수집 필요\n",
      "\n",
      "======================================================================\n",
      "🎉 윤리 평가 완료!\n",
      "======================================================================\n",
      "📊 최종 점수: 24.0/100 (등급: D)\n",
      "💡 전체 신뢰도: 0.44\n",
      "⚠️ Critical Issues: 23개\n",
      "📝 총 근거: 27개\n",
      "\n",
      "======================================================================\n",
      "🔍 재수집 필요 여부 확인\n",
      "======================================================================\n",
      "⚠️ 재수집 필요 (시도 횟수: 2)\n",
      "집중 영역: ['accountability: 회사의 문서에서 평가 기준과 관련된 정보가 전혀 발견되지 않음.']\n",
      "⚠️ 최대 재시도 횟수 도달 (2회) - 보고서 생성 진행\n",
      "\n",
      "======================================================================\n",
      "📄 [Node 5/5] PDF 보고서 생성\n",
      "======================================================================\n",
      "\n",
      "======================================================================\n",
      "📄 [PDF 보고서 생성 Agent] 시작\n",
      "======================================================================\n",
      "📝 PDF 생성 중: ethics_report_Babylon Health_medical_20251023.pdf\n",
      "✅ PDF 파일 생성 완료: ethics_report_Babylon Health_medical_20251023.pdf\n",
      "\n",
      "======================================================================\n",
      "✅ PDF 보고서 생성 완료!\n",
      "======================================================================\n",
      "📁 파일: ethics_report_Babylon Health_medical_20251023.pdf\n",
      "\n",
      "======================================================================\n",
      "🎉 파이프라인 완료!\n",
      "======================================================================\n",
      "\n",
      "📊 수집 통계:\n",
      "   웹 문서: 99개\n",
      "   전문 자료: 115개\n",
      "   총: 214개\n",
      "\n",
      "📋 평가:\n",
      "   평가 기준: 27개\n",
      "   발견 근거: 27개\n",
      "\n",
      "⚖️ 윤리 점수:\n",
      "   투명성: 30/100\n",
      "   인간 감독: 25.0/100\n",
      "   데이터 거버넌스: 20/100\n",
      "   정확도 검증: 25/100\n",
      "   책임성: 20/100\n",
      "   종합: 24.0/100 (등급: D)\n",
      "   신뢰도: 0.44\n",
      "\n",
      "⚠️ Critical Issues: 23개\n",
      "\n",
      "🆔 Run ID: 4e9e5e17-6c8d-4495-9ff7-cdf15752c827\n",
      "======================================================================\n"
     ]
    }
   ],
   "source": [
    "from ethics_pipeline_graph import EthicsPipelineGraph\n",
    "\n",
    "# ✅ 초기화 (API 키만)\n",
    "pipeline = EthicsPipelineGraph(\n",
    "    tavily_api_key=os.getenv(\"TAVILY_API_KEY\"),\n",
    "    openai_api_key=os.getenv(\"OPENAI_API_KEY\")\n",
    ")\n",
    "\n",
    "# ✅ 실행 (회사명, 도메인 지정)\n",
    "final_state = pipeline.run(\n",
    "    company_name=\"Babylon Health\",\n",
    "    domain=\"medical\"\n",
    ")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "langchain-kr-607HAWwd-py3.11",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
